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ABSTRACT 
 
 
DESIGN AND APPLICATION OF MICROFLUIDIC PLATFORMS FOR 
INTEGRATED ADIPOCYTE PERFUSION AND SECRETION ANALYSIS 
BY ENZYME ASSAY AND MASS SPECTROMETRY 
 
 
by 
 
 
Colleen Elisabeth Dugan 
 
 
Chair: Robert T. Kennedy 
 
  
 Microfluidic chips enable integration of many components onto one miniaturized 
platform, creating highly automated devices with the potential for increased throughput 
of chemical analysis processes. Chips can be adapted to load and perfuse cells; the 
continuous flow principle of these devices is more biomimetic to the in vivo cellular 
environment, and allows collection and analysis of secreted metabolites with greater 
temporal resolution. To learn more about their cellular function, polydimethyl siloxane 
(PDMS) microfluidic devices were developed to perfuse 3T3-L1 adipocytes and measure 
secreted lipolysis products. A chip was constructed that contained a cell perfusion 
chamber with integrated fluorescent enzyme assay reaction channels to simultaneously 
monitor adipocyte release of non-esterified fatty acids (NEFAs) and glycerol. This 
multiplexed analysis was measured with laser-induced fluorescence (LIF) detection. The 
NEFA assay had a limit of detection (LOD) of 6 µM and the glycerol assay had a LOD of 
 xviii 
 
5 µM; both assays had sufficient linear dynamic ranges to measure the secreted products 
at a flow rate of 0.75 µL/min. Initial studies monitored the secretion of lipolysis products 
under basal and stimulated conditions. With simultaneous detection, NEFA recycling 
could be inferred, based on the ratio of secreted NEFAs to glycerol. Further studies 
compared on-line perfusion and analysis to conventional off-line techniques in terms of 
NEFA recycling; initial findings suggest there is less NEFA recycling with on-chip cell 
perfusion. Additionally, pilot studies investigated the kinetics of lipolysis regulation by 
applying brief pulses of chemical stimuli. 
A second chip was developed to couple on-line adipocyte perfusion with mass 
spectrometry (MS) detection to learn more about the identities of secreted NEFAs. As the 
enzyme assay only permits measurement of total NEFA concentration, MS allows 
multiplexed analyte detection. An injection loop was integrated downstream of a cell 
perfusion chamber, operated with multilayer pneumatically-actuated valves. The injection 
loop acted to isolate the cells from the back pressures generated from the solid phase 
extraction (SPE) bed coupled to the chip, which was necessary to improve electrospray 
ionization (ESI)-MS efficiency. Eight NEFAs secreted from adipocytes were monitored 
under basal and lipolysis-stimulated conditions using this chip. 
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CHAPTER 1  
 
INTRODUCTION 
 
 Miniaturization and automation of chemical analysis tools has become a pinnacle 
aim of recent scientific research and discovery. The advancements of microfluidic 
techniques have been pivotal in achieving this objective. Generally hailed for their small 
footprint and reduced reagent consumption, these devices (chips) have immense 
attributes that extend much further. Microfluidic applications are incredibly broad and 
can extend many disciplines, bridging chemistry and biology, and have assisted in 
bringing advances to our knowledge on myriad topics.  
 One microfluidics application that has become momentous in recent years is the 
capability to perfuse cells on-chip. The ability to constantly flow media over cells creates 
an environment that mimics physiological nutrient circulation in vivo, and is one of many 
advantages that have been harnessed. In this dissertation novel microfluidic platforms 
that integrate on-chip cell perfusion coupled to automated, on-line analysis methods are 
described and along with their application to monitoring adipocyte metabolite secretion. 
Microfluidics 
 The essential basis of microfluidic technology is the control of fluid flow on a 
miniaturized platform. Through photolithography fabrication processes, enclosed 
microchannels are created on the order of tens to hundreds of microns. Geometries and 
designs of the channels vary depending on application and chosen substrate, often 
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offering unparalleled spatiotemporal control. Due to the reduced size of microfluidic flow 
paths, a substantial reduction of reagent/solvent use is achieved, minimizing cost and 
waste. Chips can be used repeatedly for experiments, creating an economical alternative 
to larger scale techniques. Furthermore, the sample size requirement for applications is 
significantly reduced, making it an ideal tool when limited sample volumes are 
available.1.1-3 
Microfluidic Substrates  
A number of substrates can be used to create microfluidic chips based on 
matching the most suitable properties to the application of interest. The type of 
fabrication process used to create the microchannels is also dependent upon the substrate 
used. Possible options range from silicon to glass to plastics, each with their own merits. 
Silicon was commonly used when microfluidics was initially conceived because 
microelectronic machining fabrication techniques were clearly established. However, the 
associated expense, fragility and opacity were major deterrents of its extended use. Glass 
has become the cornerstone substrate for microfluidic capillary electrophoresis (CE) with 
its inherent chemical resistance and ability to be easily modified. Additionally, glass is 
optically transparent making it compatible with many detection techniques; however, 
fabrication of glass chips is accomplished through an isotropic hydrofluoric acid wet 
etching process and cannot be readily produced in bulk. A variety of plastics have 
become popular for use as microfluidic devices: polydimethyl siloxane (PDMS), 
poly(methylmethacrylate), cyclic olefin polymers, and polystyrene, to name a few.1.4 The 
latter 3 plastics can be made with injection molding and hot embossing methods, which is 
favorable for bulk manufacturing. For the remainder of the dissertation, PDMS 
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microfluidic techniques and devices will be discussed, as that was the substrate utilized in 
all the dissertation chapters. 
 PDMS is the most widely used plastic microfluidic substrate, owing to a number 
of advantages. PDMS is transparent, allowing optical detection techniques to be 
accomplished on-chip. Optical transparency is also beneficial for general visualization of 
features on-chip, monitoring flow patterns, and checking for problems like bubbles or 
fabrication errors. PDMS is inherently elastomeric, allowing for reversible sealing and 
integrating valves (merits of which will be described in more detail in following 
chapters). PDMS is gas permeable, making it an ideal substrate for applications where 
cells or tissue are loaded on-chip. The one disadvantage of PDMS is the hydrophobic 
surface chemistry is not very chemically resistant. PDMS swells in organic solvents, and 
biomolecules and hydrophobic analytes can adsorb onto the channel walls or absorb 
further into the bulk. Figure 1.1 shows that when native PDMS channel is filled with a 
hydrophobic fluorescent dye, the chemical absorbs into the PDMS bulk over time.1.5 
 
Figure 1.1: PDMS channel filled with 10 µM rhodamine B at time 0, 1 and 4 hrs. 
Over time the analyte absorbs into the PDMS bulk, as visualized by fluorescence. 
Reprinted (adapted) with permission from Roman, G. T.; Hlaus, T.; Bass, K. J.; 
Seelhammer, T. G.; Culbertson, C. T., Anal. Chem. 2005, 77, 1414-1422. Copyright 
2005 American Chemical Society.1.5  
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PDMS Chip Microfabrication 
PDMS is fabricated through soft lithography; a master mold is made via 
photolithography and PDMS prepolymer can be recast on the mold repeatedly, making it 
compatible with large-scale production.1.6, 7 Silicon wafers act as the template base for 
forming the channels. Positive or negative photoresists are used to create the channels. 
Depending on the type of photoresist used, a clear- or dark-field transparency with the 
aerial channel design is created through a computer-aided design (CAD) program. 
Photoresist is spun on the Si wafer, hardened by baking, and the transparency is placed 
on the wafer. UV light exposure crosslinks the negative photoresist through the clear 
areas on a dark-field mask, however the areas of positive photoresist exposed to UV light 
become soluble. The last step of the mold fabrication process is to develop the 
photoresist, leaving only the rectangular channel features. This process of creating the 
PDMS mold is shown in Figure 1.2, steps a-d.  
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Figure 1.2: PDMS chip fabrication procedure. A high-resolution CAD transparency 
is printed with the channel features (a). Photoresist is spun on a Si wafer (b). 
Transparency is positioned over wafer and UV light is exposed (c). Photoresist is 
developed and only channel features remain on the wafer (d). PDMS pre-polymer is 
cast over the mold and cured (e). The PDMS can be peeled away from the wafer 
with the channel features embedded in the polymer (f). 
 A viscous PDMS prepolymer is made by mixing a base reagent and curing agent. 
The most typical ratio used is 10:1 (base:curing agent), however greater amounts of the 
curing agent compared to base reagent will create a firmer polymer upon baking (and 
conversely using less curing agent will result in a softer product). The PDMS prepolymer 
forms bubbles during mixing, but after degassing, the mixture is poured onto the mold on 
the Si wafer and baked to cure (Figure 1.2e). The PDMS can be peeled away from the 
wafer (Figure 1.2f) and irreversibly bonded to other pieces of PDMS or glass by 
changing the surface chemistry from silane to silanol groups1.8, as shown in Figure 1.3. 
This surface chemistry change can be achieved by exposing areas to be bonded to oxygen 
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plasma, corona discharge or strong oxidizing agents like Pirahna solution (3:1 
H2SO4:H2O2). The exposed silanols revert back to siloxy groups if left unbound.  
 
Figure 1.3: Surface chemistry of PDMS in the native state and with exposed surface 
silanol groups. 
PDMS Surface Modifications  
As previously mentioned, PDMS is often incompatible with many analytes, but 
extensive research has gone into developing surface modifications to combat those 
challenges. These strategies range in time and complexity, but the modification method is 
typically chosen based on the application goals of the chip. The main approaches for 
PDMS surface modification rely on passive perfusion of a solution that physically 
interacts with the surface or chemically changing the surface through covalent 
linkages.1.9-11 Passive modification techniques generally involve pumping a solution 
through the chip that will temporarily interact with the channel walls. Commonly used 
procedures involve the use of charged surfactants or biomolecules that won’t interfere 
with the on-chip assay. Sodium dodecyl sulfate (SDS) is a surfactant with a negatively-
charged head group and hydrophobic tail that can interact with the hydrophobic PDMS. 
Pumping a solution of 1 mM SDS was shown to increase the wettability of the PDMS 
microchannels1.12, 13 and increase the EOF efficiency.1.14 Polyelectrolyte multilayers can 
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be formed on channel walls through layer-by-layer deposition. Alternately charged 
polyelectrolyte solutions can be deposited on the microchannel creating a hydrophilic 
surface and preventing analyte absorption into the bulk PDMS.1.15 While these methods 
require short modification times, they can also be less stable and need to be frequently 
refreshed. Although generally having more complex procedures, covalent modifications 
offer greater longevity and stability. A few examples of covalent modifications 
preventing PDMS analyte absorption include sol-gel formation1.16 and linking 
polyethylene glycol or amine terminal groups to the wall via silanization reactions.1.8 
Fluid Flow through Chip Microchannels 
Fluid movement in microfluidic devices can be controlled in a number of 
ways.1.17 Gravity driven flow is the most basic form, not requiring any external 
equipment, making it ideal for maintaining a small footprint. Fluid is filled in an open 
reservoir and is wicked through the channels until the outlet reservoir is the same height 
as the inlet. Media can be manually replaced at the inlet (or extracted from the outlet) 
however it’s not an automated process and does not maintain a consistent flow rate. 
Vacuum or pressure driven flow are the more commonly used methods employed by 
researchers. Tubing and a vacuum pump can be connected to the outlet of the chip and 
draw fluid through the channels at a set, constant velocity. Pressure driven flow can be 
accomplished through the use of a syringe or peristaltic pump. Peristaltic pumps can be 
built on-chip and operated through the expansion of overlaid channels by adding gas 
pressure1.18 or an electric Braille module.1.19 While potentially reducing the footprint of 
the system, peristaltic pumping results in pulsatile flow, whereas a syringe pump 
produces stable flow over time. 
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 Flow through microchannels is sufficiently slow that it is in the laminar flow 
regime, wherein flow profiles can be adequately defined.1.20 As a result of laminar flow, 
two joining fluid streams will only mix laterally (across the width of the channel) by 
molecular diffusion, illustrated in  the left portion of Figure 1.4a. Complete diffusion 
(mixing) in wider, straight microchannels can be difficult, although for some applications 
like particle sorting, this property can be advantageous. A variety of channel design 
schemes have been produced that result in more rapid mixing of parallel fluid streams, 
with their efficiency often depending on fluid properties and flow rate. Passive mixers 
like serpentine networks are often the simplest to implement, but may not provide as 
rapid of mixing compared to an externally controlled active mixer.1.21 Additionally, in 
microchannels, flow along the walls is slower than in the center of the channel creating a 
parabolic profile, and resulting in Taylor dispersion1.22, shown in the right portion of 
Figure 1.4a. This phenomenon can cause band broadening and increased temporal 
resolution for on-chip assays. Droplet microfluidics is a possible circumvent for these 
problems. As shown in Figure 1.4b, this approach involves creating discrete sample plugs 
in the channel, separated by oil or air; within these droplets, temporal information can be 
retained and rapid mixing is observed.1.23, 24 
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Figure 1.4: Schematic of diffusive mixing and Taylor dispersion in a microchannel. 
As fluids from 2 streams are joined in one channel, there is minimal mixing initially. 
At longer times the chemical species undergo lateral diffusive mixing. Additionally, 
due to the parabolic flow profile in microchannels, Taylor dispersion is observed 
over time. Adapted with permission from John Wiley & Sons, Inc.1.23 
 Computer modelling programs like COMSOL Multiphysics can be extremely 
beneficial when designing microfluidic devices.1.25-27 Exact chip designs can be imported 
into the program, and different physics models can be applied to simulate flow or 
chemical species movement. Complex channel networks can be optimized in terms of 
geometric proportions and flow rate. 
Integration  
Microfluidic devices have the immense capacity to join multiple analytical 
components onto one platform, creating a ‘lab on a chip’ or micro total analysis system 
(µTAS).1.4, 28 This component integration vastly increases automation of a technique, 
scale of data acquisition, and multiplexing potential. Countless examples of microfluidic 
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integration have been demonstrated, ranging from on-chip detection1.29 to performing an 
entire polymerase chain reaction (PCR) procedure (depicted in Figure 1.5)1.30. An 
integrated component repeatedly used in this dissertation was on-chip pneumatically-
actuated valves, which allow automated manipulation of fluid flow. First described by 
Unger, et al., a multilayer PDMS chip design with overlaid channel networks is 
constructed for the valve operation.1.31 Gas pressure is applied to an upper layer channel, 
causing expansion of the elastomeric polymer and constricting a lower fluidic channel. 
Computer programs can control the activation of the gas pressure. The integration of cells 
or biological tissue on-chip was another key milestone in the complete integration of 
scientific laboratory techniques on one device and will be described further in the 
following section. 
 
Figure 1.5: Demonstration of microfluidic integration; an entire PCR is completed 
on one µTAS device. Reprinted with permission from Annual Reviews.1.32 
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Microfluidic Cell Perfusion 
 Joining biological cell analysis with microfluidic technology has created many 
advances in the understanding and diagnosis of physiological events. In addition to all the 
benefits of microfluidics, like reduction in sample/reagent consumption and increased 
automation, there are many more reasons that integrating cells on-chip is advantageous. 
The essential foundation of fluid flow with microfluidics can be equated to the 
circulatory system in vivo, constantly transporting nutrients and secreted products or 
waste.1.33 Therefore, compared to conventional static culture, perfusion of cells creates 
more physiologically relevant conditions.1.26 Fresh media can be continuously added or 
recirculated depending on application.1.34 Additionally, with microfluidics, spatial or 
temporal gradients can be generated in relation to media transport, allowing a wide 
variety of parameters to be tested on one platform.1.35, 36 
Perfusion systems in water-jacketed columns have been employed, but require 
large volumes of media and number of cells (flow rates on the order of hundreds of 
µL/min and millions of cells).1.37, 38 With microfluidics, cells can be loaded onto chips 
and cultured for extended periods of time, and in much smaller quantities than required 
for the column perfusion or static culture. Groups have even reported the capability of 
capturing and analyzing single cells, well suited in the dimensions of microchannels, 
potentially gaining understanding of their autocrine signaling.1.39 There are a few 
different methods of introducing cells into a microfluidic perfusion channel or chamber, 
but it generally depends on the properties of the cell line. Cells can be suspended, 
pumped into the chip, and then flow is briefly stopped, wherein the cells adhere to the 
surface of the chip.1.25 Flow is then resumed for the culture or perfusion experiment. 
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Another method is culturing cells on a substrate through conventional methods, and then 
transferring that material with attached cells to a chamber.1.40, 41  
Geometry, microfluidic substrate and flow design of cell chambers greatly varies 
depending on cell type and application.1.42 The first consideration when fabricating 
chambers on-chip is size of the cell line used. The height should be sufficiently greater 
than the size of the cell, but not so high that nutrients and waste are properly 
transported1.43; Kim et al. report suggested chamber heights for a variety of cell lines.1.26 
The width of the chamber will control how many cells can be seeded in a 2D monolayer 
format. Flow rates are generally optimized to a given application. Higher flow rates 
create shear stress on the cells, which can be biologically relevant to a certain point, but 
when increasingly elevated can result in morphological changes.1.44 PDMS is the most 
widely used substrate for implementing cells on-chip, as it is gas permeable and 
biocompatible, however use of other substrates have been reported.1.26, 45 
 Traditional studies performed on cell cultures often require lengthy incubation 
times (on the order of hours), which makes it difficult to gain any kinetic information 
about the system. Manual addition and removal of media is required for all static cell 
experiments, followed by off-line analysis and detection methods to identify or quantify 
an analyte of interest. Microfluidic integration of analysis techniques allows direct, 
automated assays to be performed.1.46, 47 Continuous flow allows more real time data to 
be acquired with on-line detection, as demonstrated in Figure 1.6.1.48 A new field of study 
has been coined ‘secretomics’, which is the study of secreted proteins from cells.1.49 This 
process can be easily adapted to microfluidic devices and expanded to monitor a variety 
of metabolites; different stimuli or drug treatments can be added and the secreted 
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products can be directly and continuously monitored to learn more about their 
physiology.1.48, 50, 51 Many groups have demonstrated the utility of on-line analysis of 
microfluidic cell perfusion, exemplified in Table 1, however much of the work in the 
field of integrating cells on-chip still focusses on the engineering aspects of design and 
optimization of microfluidic devices, while utilizing them to understand the biological 
aspects of the cell is lacking. 
 
 
Figure 1.6: An integrated microfluidic device, containing a cell chamber, chemical 
assay reaction channels and an on-line detection method. Reprinted with permission 
from Goto, M.; Sato, K.; Murakami, A.; Tokeshi, M.; Kitamori, T., Anal. Chem. 
2005, 77, 2125-2131. Copyright 2005 American Chemical Society1.48 
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Table 1: Examples of microfluidic cell perfusion and secretion analysis. 
Cell Substrate Analysis Detection 
3T3-L1 
Adipocyte1.40, 41, 
52 
Glass, 
PDMS 
NEFA & glycerol secretion,  
on-chip enzyme assay 
Laser-induced 
fluorescence (LIF) 
Islet1.53-55 Glass 
Insulin1.53, 54 or  
glucagon1.55 secretion,  
on-chip immunoassay 
LIF 
Chromaffin1.56 PDMS Catecholamine secretion Electrochemical 
PC121.57 PDMS Glutamate secretion MS 
Macrophage1.48 Glass NO secretion,  on-chip bioassay 
Laser-induced 
thermal lens 
microscope 
Erythrocyte1.58 PDMS ATP secretion,  on-chip enzyme assay Chemiluminescence 
 
Detection Methods 
Laser-induced fluorescence (LIF) detection methods are a popular choice for 
measuring secreted metabolites from cells. Fluorescent assays can be integrated onto the 
chip and resulting fluorophores can be detected immediately with high sensitivity and 
low detection limits.1.53, 55, 59 Given that most microfluidic substrates are optically 
transparent, chips can be positioned on an inverted microscope or optics set-up. Insulin 
secretion from islets of Langerhans has been measured via an on-chip fluorescent 
immunoassay and detected with LIF.1.54 The pulsatile release of insulin phases is possible 
to measure with this microchip; 6 s injections were made, and the system had a detection 
limit of 0.8 nM. A follow-up to this study demonstrated the potential of microfluidics to 
allow parallel sampling of islets from 15 cell chambers on the same platform.1.60 
 Mass spectrometry (MS) is an alternative detector for coupling to microfluidic 
devices.1.61 The electrospray ionization (ESI) source allows continuous flow into the MS, 
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which allows for rapid, sensitive, and multiplexed detection of secreted cellular 
metabolites. Unlike LIF, MS has the advantage that no fluorescent tag is necessary. 
Groups have reported direct, on-line microfluidic connection to MS, but generally 
involve cell lysis or biological samples that have been pre-processed off-chip (cite).1.62-65 
However, cell perfusion buffers contain high salt content, which is not amenable with 
ESI, which has been a challenge in creating cell chip-to-MS systems. Salt leads to ion 
suppression and decreased signal intensity of the analyte of interest.1.66, 67 Pretreatment or 
clean-up methods incorporated between the sampling region and MS is a way around this 
challenge.1.66 One group has reported incorporating a solid phase extraction bed into a 
microfluidic system to monitor glutamate release from neurons under different 
concentrations of stimuli.1.57 Secreted metabolites from the cells in the chamber load onto 
the SPE bed, the bed was washed to remove salts and other interfering media 
components, and the analyte was eluted to the MS (pictorial schematic shown in Figure 
1.7). This method is not completely on-line as manual connection and movement of 
tubing is necessary during the course of the experiment, but was a demonstration of 
microfluidic cell perfusion to MS. 
 
Figure 1.7: A system devised to couple on-chip cell perfusion with MS detection. 
Cells are incubated in chambers and media is flowed from the chamber onto a 
packed SPE bed in a subsequent chip. That chip is then disconnected from the cell 
chamber chip, the SPE bed is washed and analyte is eluted continuously into the MS 
ESI source. Reproduced with permission from The Royal Society of Chemistry.1.57 
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Adipocyte Metabolism 
As previously discussed, the extent and versatility of microfluidic cell culture and 
analysis has grown in recent years, but little research has delved into monitoring 
adipocytes on-chip. Dysfunction of adipocyte metabolism can lead to various obesity-
related disorders like type 2 diabetes1.68-71, which have a huge economic impact on the 
healthcare industry. Researchers are still continuing to understand the complexities of this 
tissue and how different factors lead to these conditions. Therefore in this dissertation, 
novel microfluidic devices have been developed to learn more about the secretion of 
metabolites from adipocytes. 
Mammalian fat stores reside in adipocytes, where the majority of the cell volume 
is a lipid droplet.1.68 The adipocyte lipid droplet is comprised mainly of triglyceride 
molecules; a glycerol backbone with 3 attached fatty acid moieties.1.68 An intrinsic 
metabolic process in adipocytes is lipolysis, the catabolism of the triglyceride molecule 
into glycerol and non-esterified fatty acids (NEFAs). Glyercol is secreted by the 
adipocyte and transported predominantly to the liver; however, depending on energy 
requirements of surrounding tissues, NEFAs can be released from the adipocyte or 
recycled back into the adipocyte for continued storage, as shown in Figure 1.8.1.68, 72 This 
process, known as NEFA re-esterification or recycling, is vital in moderating energy 
distribution.1.73, 74 Both lipolysis and NEFA re-esterification are highly regulated 
functions of cellular homeostasis, responding to (and secreting) a variety of signaling 
molecules, making adipose tissue a central entity of the endocrine system.1.75-77 
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Figure 1.8: Graphic representation of lipolysis and NEFA recycling in adipocytes. 
Reproduced with permission from Nature Publishing Group.1.78 
During energy excess or postprandial states, enzymatic and hormonal signaling 
molecules promote increased exogenous fat storage and NEFA recycling, and decreased 
lipolysis.1.69, 70, 79 Contrastingly, during fasting states, lipolysis rates are elevated.1.69, 79, 80 
In vitro or ex vivo experiments use secreted glycerol concentration as an indicator of 
lipolysis rate; due to the lack of glycerol kinase in the adipocyte, glycerol cannot be 
directly re-esterified into a triglyceride molecule like NEFAs.1.72 The rate of NEFA 
recycling can be inferred by measuring the secreted concentration of NEFA and 
comparing to the amount of glycerol release; complete lack of any NEFA recycling 
would result in a 3:1 concentration ratio of released NEFAs to glycerol. Physiologically 
that ratio isn’t observed as 30-40% of NEFAs are immediately recycled into the lipid 
droplet.1.73, 76 Glycerol-3-phosphate (G3P) is necessary to generate new triglyceride 
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molecules through NEFA re-esterification. Since glycerol is generally not a source of 
G3P in the adipocyte, other precursors are utilized: predominantly glucose during the fed 
state and glyceroneogenic precursors (i.e. pyruvate, lactate, amino acids) in fasting 
states.1.80, 81  
Secretion of glycerol and NEFAs from adipocytes has been sampled through a 
few different methods: sampling supernatant media in static culture1.82, 83, perfusing cells 
in a large-scale column1.37, 38, 84, and collecting blood aliquots via catheterization1.85, 86. 
The latter method has the benefit of in vivo measurement (i.e. adipocytes are exposed to 
the matrix, vasculature and signaling molecules of their native environment), however 
there is less control of external parameters and it only provides a systemic evaluation. 
Sampling from static culture is the standardized approach and comparisons can easily be 
made to literature reports from other groups, but it doesn’t offer any kinetic information 
and the extracellular environment is less biomimetic than a flow system. Perfusion of 
cells in a column incorporates the principle of fluid circulation, but large cell numbers 
and reagent volumes are required, and manual fraction collection is necessary. Therefore, 
microfluidic technology can be beneficial for understanding more of the fundamental 
aspects of lipolysis and NEFA recycling. 
A variety of adipocyte cell types can be used to understand more about adipose 
biological mechanisms in vitro. As a cultured murine cell line, 3T3-L1 adipocytes are one 
of the most frequently used type due to their ease of culture/differentiation, aptitude to 
adhere to surfaces and ability to passage numerous times in the pre-adipocyte stage. Since 
they are so frequently employed for in vitro experimentation, vast literature sources 
provide comparison to experimental data. In terms of representing human adipose tissue, 
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3T3-L1 cells contain multilocular lipid droplets and are aneuploid in nature (containing a 
different number of chromosomes and missing genes)1.87, 88 and therefore not always the 
most ideal model. Murine stem cells can also be used, when induced to commit to the 
adipogenic lineage.1.89 Ear mesenchymal stem cells (eMSCs) can be obtained from mouse 
ear punches, and have the advantage of carrying the same genetic model as the host mice 
(ie. knockout lines).1.90 Primary adipocytes are the third commonly used cell type, as they 
are derived from a fat pad in a host animal and are therefore contain the most 
physiologically relevant qualities.1.91 They are comprised of unilocular lipid droplets and 
can be collected from a variety of fat depots, allowing differences in function among the 
depots to be monitored.1.88 However, primary cells can be more difficult to handle as they 
float in media.  
3T3-L1 adipocytes will be used as the cell model line in all of the dissertation 
chapters, due to the relative simplicity of culturing, handling and incorporation into a 
microfluidic cell chamber. Despite the fact that 3T3-L1 cells are easier to adapt to on-
chip adipocyte perfusion studies, care must still be taken to ensure the cells maintain their 
normal function under continuous flow. This entails creating the appropriate chamber 
design and flow rate parameters that are amenable with their inherent fragility and 
buoyancy. Furthermore, in comparison to other types of cells, adipocytes have lengthy 
culture durations, necessary to accumulate sufficient lipid. This creates a challenge when 
integrating on-chip; cells must be able to be cultured on-chip for that period of time or 
transferred once mature.  
Previously, chips have been developed that integrate an adipocyte cell perfusion 
chamber with on-line enzyme assay and LIF detection to measure secreted concentrations 
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of glycerol or NEFAs.1.40, 41 Adipocytes were grown using conventional static culture 
procedures on pre-cut glass coverslips prior to loading on-chip. Because of this, the chip 
needed to have a reversibly-sealed cell chamber. These experiments were conducted in 
glass chips, which were advantageous because of their chemical resistance, however 
creating an efficient and reproducible seal of the glass layers was challenging. The 
multilayer device with reversibly-enclosed cell chamber is shown in Figure 1.9. 
Furthermore, only one assay could be performed on these designs.   
 
Figure 1.9: Multilayer glass chip developed to perfuse 3T3-L1 adipocytes on-chip 
followed by integrated enzyme assay reaction channels to continuously measure 
secreted NEFAs. Reproduced with permission from Springer.1.40 
Dissertation Overview 
 In this dissertation, novel PDMS microfluidic devices have been developed with 
integrated cell chambers coupled to on-line detection techniques to monitor secreted 
metabolites. These systems allow continuous, automated analysis of cellular secretion, 
not possible with traditional techniques. Adipocytes were used herein as the model cell 
line, with the goal of learning more about secreted lipolysis products, glycerol and 
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NEFAs. Furthermore, the technology developed may have application to measuring the 
chemical environment around other cells that are grown on microfluidic chips. 
 Chapter 2 describes the development of a multilayer PDMS chip to 
simultaneously measure glycerol and NEFA release from on-chip perfused adipocytes. 
This integrated system made use of commercially available enzyme assay reagents to mix 
on-chip with the cell perfusate. The flow from the cell chamber was split into 2 chemical 
reaction channels, to conduct separate NEFA or glycerol enzyme assays. A fluorescent 
product was created through the enzyme assay and LIF detection was used for monitoring 
concentrations of the secreted metabolites. A reversibly-sealed chamber allowed re-use of 
the chip. On-chip valves allowed more automated delivery of chemical stimuli to the 
cells. This device is the first of its kind to demonstrate multiplexed analyte detection of 
secreted metabolites from cells on chip. Data and analysis of this research was published 
in Analytical and Bioanalytical Chemistry in 2014 and has been reproduced in this 
dissertation.1.52 
 In Chapter 3, a novel PDMS chip for coupling on-line adipocyte perfusion to MS 
detection is described. A multilayer, reversibly-sealed cell chamber was integrated with 
an injection loop on one device. The injection loop was operated with a series of 
microfabricated, pneumatically-actuated valves. The chip was directly connected to an 
off-chip capillary SPE bed and ESI spray tip. The SPE bed can generate backpressures, 
so the injection loop acts to fluidically isolate the SPE packing from the cell chamber; 
increased backpressures on the cells can be detrimental to inherent function. This set-up 
was positioned by the MS source and secreted NEFAs were identified under basal and 
stimulated conditions. 
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 Chapter 4 outlines a series of biological experiments that were conducted on 
adipocytes in the chip developed in Chapter 2. Taking advantage of the ability to 
continuously monitor secreted metabolites from cells on chip, short stimulation 
experiments were performed to learn more about the kinetics of lipolysis. Additionally, 
cells of different age in culture were loaded on-chip to monitor the changes in lipolysis 
and NEFA re-esterification as a function of cell maturation. Finally, results from on-chip 
experiments were compared to traditional static culture analysis, to see how continuous 
perfusion of cells during analysis influences NEFA re-esterification. 
 Chapter 5 summarizes the findings from the aforementioned chapters. A series of 
follow-up and future experiments are proposed for continued understanding of adipocyte 
lipolysis and NEFA re-esterification, and as well as possible suggestions for improving 
the robustness and reproducibility of the chips detailed in Chapters 2 & 3. 
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Introduction 
 Microfluidic and lab-on-chip devices offer many benefits for analytical 
measurements over traditional techniques including reduced reagent and sample volumes, 
improved temporal resolution for monitoring, and increased automation. Such devices 
have also become powerful tools for cell biology.2.1, 2 Specific cell lines or individual 
cells can be isolated in the reduced dimensions of a microfluidic device.2.3, 4 Cells can be 
perfused in two or three dimensions with continual replenishment of media to more 
closely mimic the in vivo environment compared to traditional static incubation 
methods.2.5, 6 Microfluidics also provides a way to miniaturize and provide higher 
throughput of cell culture-based experiments. Although growing cells in chips can be 
useful, in many cases it is also necessary to assess cell function. Visual inspection and 
fluorescence measurements of cells are straightforward on chips that are optically clear; 
however, chemical analysis of the cellular environment often requires other assays. 
Although chemical measurements can be performed off-chip2.7, integrating analytical 
measurements with cells on microfluidic systems eliminates the need for sample 
collection and off-line analyte detection, and can provide real-time recording of cellular 
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dynamics.2.8, 9 Several examples of this approach have been described including on-line 
immunoassays2.10, sensors2.11, and enzyme assays2.12. Most such systems perform a single 
assay on cells. In this chapter, we describe an advance on this capability in a system 
fabricated in polydimethylsiloxane (PDMS) that uses dual on-line enzyme assays to 
monitor metabolic activity in near real-time. We also demonstrate a method to avoid 
chemical loss to absorption by PDMS that improves sensitivity of measurements of 
hydrophobic compounds such as fatty acids. 
 Adipocytes were used as a model system for these experiments. Adipocytes are 
fat-storing cells that secrete glycerol and non-esterified fatty acids (NEFA) as a result of 
the catabolism of triglycerides through lipolysis. Flux of lipolytic products is regulated by 
a variety of signals. The adipocyte re-esterifies (recycles) a percentage of the NEFAs 
back into triglycerides, as a method of regulation for systemic NEFA supply.2.13 
Depending on the physiological energy state, different enzymes and glycerol-3-phosphate 
precursors dictate the pathway and amount of recycling.2.14, 15 Increased adiposity, as in 
obese individuals, is often associated with a number of disorders including type 2 
diabetes.2.16-19 Thus, understanding the mechanisms of fatty acid recycling and the factors 
that lead to its dysfunction could be fundamental to providing improved treatment for 
obesity-related disorders. 
 Adipocytes have been previously mounted in microfluidic devices, mainly to 
monitor differentiation and culture of the cells on-chip.2.20, 21 The influence of adipocyte 
secretions on other cell lines in a multi-chamber chip has also been monitored.2.22 Despite 
these advances in using microfluidics to better understand adipocyte biology, automated 
and real-time quantification of adipocyte secretion is lacking. 
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Previous reports from our group have shown the ability to monitor either NEFA 
or glycerol secretion from 3T3-L1 adipocytes on glass microfluidic devices.2.23, 24 These 
chips showed the potential to detect adipocyte secretion on-line, but individual 
measurements of NEFA or glycerol cannot provide information on fatty acid re-
esterification. The concentration of glycerol secreted from adipocytes is a direct 
indication of the rate of lipolysis; glycerol is not directly recycled by the adipocyte 
because of the lack of sufficient glycerol kinase in the cell.2.25-27 If NEFA secretion can 
be monitored at the same time as glycerol, from the same group of cells, the amount of 
fatty acid re-esterification can be inferred based on the rate of lipolysis and concentration 
of secreted NEFAs. 
To accomplish dual analyte measurement, a microfluidic chip with two enzyme 
assay reaction networks was designed. Cultured murine 3T3-L1 adipocytes were perfused 
in a cell chamber, and the resulting perfusate was split into the two enzyme assay reaction 
channels. The chip design and reagent flow rates were chosen to provide good on-line 
assay sensitivity and response time. PDMS was chosen as the microfluidic substrate 
because of many convenient properties. PDMS is biocompatible and gas permeable, 
making it well suited for cell studies.2.28 The inherently elastomeric PDMS permitted 
easier integration of a valve system, which was constructed upstream of the cell chamber 
to allow automated stream selection, reduce dead volume and prevent flow disruption 
when changing solutions. Despite the advantages of PDMS, it can absorb hydrophobic 
molecules. Since NEFAs are being detected on-chip, a surface modification was 
performed to prevent loss of the analyte. These improvements allow a rapid, automated 
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measurement method for monitoring adipocyte fatty acid re-esterification, and can be 
extended to other adipocyte secretion studies.  
Experimental 
Reagents 
The fatty acid assay reagents and standard solution (oleic acid) were purchased in 
a kit, HR Series NEFA-HR(2), through Wako Chemicals USA, Inc. (Richmond, VA). 
Amplex UltraRed Reagent, Hank’s buffered salt solution (HBSS, Cat. # 14175) and cell 
culture reagents were received from Life Technologies (Carlsbad, CA). Triton X-100 was 
purchased from Bio-Rad Laboratories (Hercules, CA). Free glycerol reagent, standard 
glycerol solution, fatty acid free bovine serum albumin (BSA), isoproterenol 
hydrochloride, sodium dodecyl sulfate (SDS), dimethyl sulfoxide (DMSO) and 
hexamethyldisilazane (HMDS) were obtained from Sigma-Aldrich (St. Louis, MO). 
Microfluidic Chip Fabrication 
The multilayer PDMS chips were fabricated with soft lithography techniques as 
previously described.2.28-30 All of the PDMS used in the chip fabrication was RTV-615 
(Curbell Plastics, Livonia, MI) and had a 10:1 base:curing agent ratio. The 4 PDMS 
layers are denoted ‘control layer’, ‘mixing channel layer’, ‘lower cell chamber layer’ and 
‘blank layer’. For the fabrication of the control layer, HMDS was spun on a 3-inch silicon 
wafer (University Wafer, Boston, MA) to facilitate photoresist adhesion. SU-8 2075 
photoresist (MicroChem, Newton, MA) was spun onto the wafer to create a 60 µm layer 
and patterned using a dark-field photomask with the design shown as the black lines in 
Figure 2.1a. A thick layer (~1 cm) of PDMS was poured over the mold and heated to 80 
°C for at least 30 min. The mold for the mixing channel layer was made the same as the 
 34 
 
control layer, but with the pattern shown as the black lines in Figure 2.1b. After the SU-8 
photoresist was developed, a 12 µm thick layer of AZ-9260 photoresist (Capitol 
Scientific, Austin, TX) was spun onto the wafer. The final pattern of the AZ photoresist is 
shown in Figure 2.1b as the red line. The wafer was heated at 125 °C for 5 min to round 
the AZ features. PDMS was spun on the wafer to create a 60 µm thick layer and heated to 
80 °C for at least 30 min. The fabrication of the lower cell chamber layer was done with 
SU-8 2075 as described above, but to a thickness of 250 µm, with the pattern shown in 
Figure 2.1c. PDMS was poured over the mold and manually distributed across the wafer 
to create a ~1 mm thick layer. The PDMS was allowed to settle for 10 min before it was 
heated to 80 °C for at least 30 min. Finally, PDMS was spun on a blank wafer to a 
thickness of 170 µm and heated to 80 °C for at least 30 min, to create the blank layer. 
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Figure 2.1: Design of the 3 different fabricated layers in the PDMS multi-layer chip. 
The control layer (a), the reaction channel layer (b), and the base chamber layer (c) 
fabrication patterns are shown. The fluorogenic dye, Amplex UlraRed, is 
abbreviated as AUR. The blue circles in (a) represent the points where access holes 
were punched through the PDMS, and the red line in (b) indicates the portion of the 
design that was fabricated with AZ photoresist. 
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The control layer PDMS was peeled away from the mold, and access holes were 
punched at the points indicated in blue in Figure 2.1a using a blunt 20 gauge needle 
(Small Parts, Logansport, IN). The control layer was bonded to the top of the mixing 
channel layer using corona discharge, and heated to 80 °C for 15 min. The two bonded 
layers were peeled from the mixing channel layer mold, bonded to the blank layer PDMS 
to enclose the channels, and heated to 80 °C for 15 min. The three bonded layers were 
peeled from the wafer and the blank layer PDMS was removed from inside the upper 
portion of the cell chamber using a scalpel blade. A 4.8 mm x 4.8 mm piece of cover 
glass (No. 1, Fisher Scientific, Waltham, MA) was bonded to the inside of the upper cell 
chamber.  The lower cell chamber layer was peeled from the wafer mold and bonded to a 
glass slide (0.55 mm thick, Telic, Valencia, CA), feature side exposed, and heated to 80 
°C for 15 min. The side view of the assembled chip is shown in Figure 2.2. 
 
Figure 2.2: Side view of chip slice showing fabrication layers and direction of flow.  
The dotted lines represent the interfaces between layers that were irreversibly 
bonded. 
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Adipocyte Culture 
Glass coverslips (No. 1, Fisher Scientific) were cut to 4.8 mm x 4.8 mm squares 
using a dicing saw. The coverslips were sterilized in 70% ethanol for at least 1 h, and 
were then dried in a sterile culture hood. Three to four coverslips were placed in each 35 
mm petri dish using sterile tweezers prior to seeding preadipocytes. Murine 3T3-L1 
preadipocytes were seeded into the 35 mm dishes (200,000 cells per dish), maintained in 
Dulbecco’s modified Eagle’s medium (Cat. #11965-092, Life Technologies) with 8% v/v 
bovine calf serum (Denville Scientific, South Plainfield, NJ), 100 units/mL penicillin, 
100 µg/mL streptomycin, 2 mM L-glutamine, 1 mM sodium pyruvate, and stored in an 
incubator with 10% CO2. Two days after the cells became confluent, differentiation 
(adipogenesis) was induced by adding 500 µM methylisobutylxanthine, 1 µM 
dexamethasone and 5 µg/mL insulin. Two days post-differentiation, medium was 
replaced with adipogenic medium that contained 5 µg/mL insulin. Adipogenic medium 
was the same as the preadipocyte medium except 10% fetal bovine serum replaced the 
bovine calf serum. Every two days following, culture medium was refreshed with 
adipogenic medium that did not contain insulin. Adipocytes were matured to at least 14 
days post-induction before on-chip experiments. 
Computational Modeling 
The perfusion of the cell chamber and mixing channels were modeled using 
COMSOL Multiphysics 4.3b (COMSOL, Inc., Burlington, MA).  The ‘Laminar Flow’ 
and ‘Transport of Diluted Species’ physics models were used to monitor the flow split 
and theoretical temporal resolution of the system. All simulations assumed water 
perfusing through the chip, with a density of 998 kg m-3 and viscosity of 1.002 x 10-3 Pa s 
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(20 °C). The cell chamber and mixing channel network were modeled separately in order 
to reduce computation times with finer meshes. The cell chamber was modeled in a 3D 
geometry and had dimensions of 5.0 mm x 5.0 mm x 0.33 mm with a 4.8 mm x 4.8 mm x 
0.15 mm box removed from top to mimic the bonded coverslip in the actual chip. The 
inlet and outlet channels for the cell chamber were 60 µm tall. Based on initial cell 
experiments, the optimal flow rate to perfuse over the cells was 0.75 µL/min, so the cell 
chamber inlet was also set to that flow rate. The channels in the assay reaction channel 
network were modeled in 2D with the shallow channel approximation set to 60 µm.  
Reversible Chip Assembly 
The PDMS was cut so that the ends of the channels were exposed.  Fluidic 
connections were made by inserting 50 µm ID/150 µm OD fused silica capillaries 
(Polymicro Technologies, Phoenix, AZ), ~13 cm long, with rounded tips into the exposed 
inlets (between the mixing channel layer and the blank layer). Sheath capillaries (180 µm 
ID/360 µm OD) were glued to the opposite ends of the 50/150 capillaries, to allow for 
easier connections to external pumps.  An additional 17 cm of 100/360 capillary was 
connected to the valve waste capillaries during experiments to balance the back pressure. 
The enzyme assay mixing channels were modified by pumping 20 mM SDS 
solution through both of the mixing channel outlets at 1.5 µL/min for 45 min. The 
channels were then flushed with water for an additional 20 min at the same flow rate. 
After every use of the chip, this process was repeated to refresh the treatment. 
The control channels were operated by connection to an in-house built 
pneumatically-actuated system. A stainless steel tube (23 gauge, ~1 cm long) was 
inserted halfway into Tygon tubing (1/16” OD, 0.5 mm ID, IDEX, Lake Forest, IL). The 
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other half was inserted into the top of the chip where the access holes were punched in 
the control layer. The Tygon tubing was filled with water and 15 psi of nitrogen gas was 
applied to the desired channels with the aid of an in-house written LabView program. 
 Before the chip was used for an experiment, it was degassed in a vacuum chamber 
for ~1 h to reduce the presence of bubbles in the channels during perfusion. The channels 
were primed with water after the chip was degassed. The two parts of the PDMS chip 
were rinsed with 70% ethanol and dust was removed with Scotch tape. For cell 
experiments, a coverslip with ~48,000 attached 3T3-L1 adipocytes was removed from the 
culture dish with sterile tweezers and placed in the lower cell chamber. Cells per 
coverslip were roughly estimated by assuming an even distribution of cells on the culture 
plate so that the number of cells equaled the fraction of plate area occupied by the 
coverslip times the total number of cells. Total number of cells was estimated from the 
number of preadipocytes seeded onto the plate (measured by hemocytometer) and the 
replication rate during differentiation. About 10 µL of culture medium was added to 
prevent trapping bubbles during sealing. For calibration experiments, a blank coverslip 
was placed in the lower cell chamber. The upper cell chamber was aligned over the lower 
chamber and the two parts of the chip were pressed to make a conformal contact.   
A compression frame to enclose the PDMS chip was built in-house from 2 sheets 
of acrylic plastic. Holes were drilled through both sheets along the outer edge to allow 
screws to pass through both sheets and tighten the compression frame. Additionally, four 
holes were drilled on the top for access to the control channel tubing, and a large 
chamfered hole was drilled on the bottom to allow the microscope objective to have 
closer access to the detection channels. The control tubing of the assembled chip was 
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threaded through the compression frame, and screws tightened the compression frame 
over the chip. Figure 2.3 shows the assembled chip in the compression frame. 
 
Figure 2.3: The assembled chip in compression frame.  Blue food dye is being 
perfused through one of the valves for better visualization. The arrows highlight the 
capillary connections and the direction of fluid flow. 
Perfusion 
The fatty acid assay reagents were reconstituted as follows: Color Reagent A 
(CR-A) was reconstituted with 30 mL of solvent A (creating a solution 1.66x more 
concentrated than manufacturer specifications) and Color Reagent B (CR-B) was 
reconstituted with solvent B according to manufacturer instructions. CR-A was further 
modified by adding 200 µL 10% (v/v) Triton X-100 to every 800 µL CR-A. The free 
glycerol reagent was reconstituted with 40 mL 18.0 MΩ/cm distilled water.  Amplex 
UltraRed was reconstituted with DMSO to make a 10 mM stock solution. The Amplex 
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UltraRed stock solution was further diluted to make a 1 mM solution in 35% DMSO, 
which was used for the on-line assays. 
Prior to performing cell studies, calibrations were performed to characterize the 
actual delay and rise times of the two multiplexed assays.  For these experiments, 
standards were diluted in HBSS containing 2% BSA (w/v) and pumped through the 2 
valve inlets at 0.75 µL/min. When an additional standard was required (i.e., when 
creating a calibration curve with multiple standard concentrations), the solution that was 
being directed to waste through the valve was replaced, which prevented disruption in the 
flow. The glycerol assay was performed by adding the glycerol reagent and 1 mM 
Amplex UltraRed solution onto the chip at 0.29 µL/min (each) at the locations indicated 
in Figure 2.1b.  The modified CR-A, CR-B and 1 mM Amplex UltraRed solutions were 
pumped at 0.30 µL/min (each) through the respective inlets shown in Figure 2.1b. All 
solution pumping was controlled by external syringe pumps. During cell experiments, 
one valve inlet was perfused with 2% BSA in HBSS (to monitor basal secretion) and the 
other valve inlet was perfused with 20 µM isoproterenol in HBSS with 2% BSA (to 
create lipolysis-stimulated conditions).  
Detection 
An Olympus IX71 inverted microscope was used to collect the signal from the 
fluorescent assay product. The light path was directed by a 10x, 0.40 numerical aperture 
objective (Olympus Part# 1-U2B823) and the appropriate mirrors/filters for resorufin 
detection.  A Hamamatsu ImagEM X2 CCD camera allowed simultaneous detection of 
the 2 outlet channels at the point shown in Figure 1b.  Data was collected at 2 Hz with an 
exposure time of 250 ms, and was analyzed with Microsoft Excel 2007. 
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Results & Discussion 
Overview of Microfluidic Chip Design 
In previous work we demonstrated different chips that could monitor NEFA and 
glycerol release from adipocytes.2.23, 24 In these chips, cells were perfused, enzyme assay 
reagents were added on-line to mix with the perfusate, and reaction products were 
measured by fluorescence detection. The reagents for the NEFA assay contained 
coenzyme A (CoA), ATP, acyl-CoA synthetase, and acyl-CoA oxidase.2.24 The glycerol 
assay reagent contained ATP, glycerol kinase, and glycerol phosphate oxidase.2.23 Both 
assays create hydrogen peroxide from their respective reactions, which can then be 
reacted with peroxidase and Amplex UltraRed to create a fluorescent product. These 
chips demonstrated important principles such as loading pre-differentiated adipocytes on 
glass coverslips into reversibly sealed chips, prevention of shear stress on the fragile cells 
during perfusion, and continuous monitoring which were used in this work. To achieve 
simultaneous analysis capability we designed a chip (Figure 2.1) that split the perfusate 
and directed the flows to two separate, continuously operating enzyme assay streams. The 
detection points for the two assay channels were placed near each other so they could be 
imaged on a fluorescence microscope. Because the enzyme assays yielded the same 
fluorescent product, this arrangement allowed glycerol and NEFA to be monitored on-
line simultaneously as they were secreted from the cells. Other improvements were also 
made including lowering the flow rate to cell ratio to reduce dilution of secreted 
chemicals by 11-fold. The new chip also integrates valves to automate physiologic 
experiments that require changing the perfusion conditions, e.g. adding drugs to the cells. 
Because valves are easily incorporated into PDMS by multi-layer lithography, we used 
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this material instead of glass. This change in material necessitated surface modification 
procedures that prevented adsorption of hydrophobic analytes to the chip.  
Simultaneous Assay Chip Design and Flow Splitting 
Stable and reliable split of the perfusate flow for each enzyme assay required 
careful consideration of the geometry and flow rates used. Although the assay reaction 
channels had approximately the same flow resistance, the different number and 
placement of reagent inlets required for each assay (see Supplementary Information 
section for pilot studies on individual assays), created differences in back-pressure. These 
differences made it difficult to predict how reagent flow would affect the perfusate flow 
into the two assay channels. To assist in determining the flow conditions, a COMSOL 
model was developed. 
For simplicity, we operated the chip with a 50:50 split of perfusate to each assay 
channel. We also fixed the NEFA assay flow rates and adjusted glycerol reagent flow 
rates because the glycerol assay was more sensitive and adaptable to changes in analyte 
to reagent ratios than that of the NEFA assay. Based on data from the single channel chip 
for NEFA detection, the highest sensitivity response was achieved when the analyte to 
reagent ratio was set to 1.25:1:1:1 NEFA:CR-A:CR-B:Amplex UltraRed. Assuming an 
even flow split, and a flow rate of 0.75 µL/min through the cell chamber, this ratio 
required that the NEFA reagents be set to 0.3 µL/min. To determine the glycerol reagent 
flow rates that were needed, we used the COMSOL model to vary flow rates from 0.1 
µL/min to 1 µL/min. The model showed that the 2 reagent inlets on the glycerol assay 
side of the chip should be set to 0.29 µL/min to achieve even flow split. The velocity map 
of the flow split using these flow rates is shown in Figure 2.4a. The map shows an even 
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split under these condition. It also shows a slight decrease in velocity before the split, 
which is due to a slight widening of the channel before the split. Additionally, it was 
determined that if the glycerol reagent flow rates were higher than 0.7 µL/min, 100% of 
the flow coming from the cell chamber would be directed to the NEFA assay channel 
showing the sensitivity of the system to changes in flow. Similarly, we found that that 
abrupt changes in pressure, such as from rapidly inserting capillaries or making 
connections, could result in unstable flows in the system.  
 
Figure 2.4: COMSOL modeling of the dual chip. (a) The velocity of laminar flow at 
the flow split allowed the ratio of cell perfusate that would be directed into each 
assay reaction channel to be determined. (b) The mixing efficiency could be 
measured at a reagent inlet by injecting a 5 µM chemical species at the flow split 
and a blank solution at the reagent inlet, and finding the point in which complete 
diffusion has occurred across the width of the channel. (c) A concentration gradient 
moving through the cell chamber when a 5 µM chemical species was injected was 
modeled to show the profile of flow across the width of the chamber. 
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To confirm that flow was symmetrical through both assay channels, we measured 
the flow rate through each channel separately. To do this, water was perfused through the 
chip and fractions were collected at the outlets every 2 min and weighed. The results 
were compared to theoretical values of 0.96 µL/min at the glycerol outlet and 1.28 
µL/min at the NEFA outlet, assuming an even flow split of the cell chamber perfusate 
into the 2 reaction channel networks. (The NEFA channel should have a higher net flow 
out because of the extra reagent channel.) The flow rate exiting the chip was 1.0 ± 0.02 
µL/min on the glycerol side and 1.3 ± 0.08 µL/min on the NEFA side (n = 4). The results 
show that the appropriate flow rates were exiting the chip and confirm an equal flow 
split. 
We also used the model to confirm that complete mixing of reagents and sample 
would occur at the flow rates and channels used. As shown in Figure 2.4b, complete 
mixing was found after the fluid traveled 7 mm through the 100 µm wide serpentine 
channels. Another important issue for design is determining whether the cells are evenly 
perfused and if the chamber is well-swept. COMSOL modeling also assisted in 
establishing the appropriate flow profile through the cell chamber. Varying the number 
and angle of the channels leading to and from the chamber changed the profile and 
temporal response of the chip. It was desired to reduce the rise time of the system to 
detect cellular dynamics, therefore a flat even flow across the chamber was ideal. Figure 
2.4c illustrates a simulation of a chemical species injection into the chamber to allow 
visualization of the flow profile of the cell chamber used in these experiments. 
Chip Characterization 
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Figure 2.5a shows the detector response to a series step changes in analyte 
concentration performed on-chip. Figure 2.5b illustrates the resulting calibration curves 
for both assays. The limit of detection (LOD) was calculated as the concentration 
corresponding to a signal that was 3 times the standard deviation of the blank. The 
glycerol assay had a LOD of 5 µM and was linear through 110 µM. The NEFA assay had 
a LOD of 6 µM and had a linear calibration through 150 µM. The calibration curves were 
reproducible over multiple experiments using the same chip with RSD of slope and 
intercept below 6% (n = 4 chips, each used for at least 3 trials).  
 
Figure 2.5: Dual chip calibration. (a) Detector trace (plotted as relative fluorescence 
units, RFU) from step changes of glycerol and NEFA standards in the dual chip, 
which are simultaneously detected. The resulting calibration curve for the glycerol 
assay (b) for 4 replicate experiments show a linear response through 112 µM, a LOD 
of 5 µM and R2 of 0.998. The fatty acid assay (c) is linear through 150 µM, and has a 
LOD of 6 µM and R2 of 0.999 for 4 replicate experiments. 
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These data also allow us to characterize the temporal response of the chip.  The 
rise time was defined as the amount of time between a 10-90% change in signal when 
standard concentrations were switched. The delay time was calculated as the time 
between switching a solution and the initial 10% rise in signal. The rise times for the 
complete assembled chip were 2.3 ± 0.6 min for both the glycerol and NEFA assays. The 
delay times were 10.2 ± 0.3 min. The COMSOL model of the chip (including the same 
flow components such as valves, cell chamber, and mixing channels) predicts 4.6 min 
and 15.4 min for the rise and delay times of the glycerol assay, and 4.7 min and 17.8 min 
for the rise and delay times of the NEFA assay, respectively. The longer times predicted 
than observed suggest a difference in geometry that is not accounted for by the model. A 
likely source of the discrepancy is reduction of channel height caused by the compression 
frame closing off the channels of the compliant PDMS.  Because the flow rates were 
through each channel as predicted (see above), the compression must have an equal effect 
on both sides of the chip. Experimental values were consistent across multiple chips and 
were used for subsequent calculations, such as accounting for delay times, related to cell 
experiments.  
An important aspect of cell physiology experiments is manipulating the solutions 
flowing over cells. In prior work2.23, 24, changing solutions was accomplished by 
switching connections to the chip. Making manual connections requires a stopping and 
starting flow and creates a change in pressure on-chip, which affects the detected signal. 
This effect is especially problematic in a dual channel chip with multiple flow paths. 
Figure 2.6a illustrates the effect on signal of such a switch. The use of fabricated valves 
on-chip significantly improved the stability of the flow through the chip when solutions 
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were switched, creating smooth step changes, as shown in Figure 2.6b. This addition also 
reduced dead volumes of the perfused solutions and increased automation of the device.  
 
Figure 2.6: Step changes on glycerol assay independent chip from high to low 
concentration standards without (a) and with (b) fabricated valves. 
Assay and PDMS Modifications 
Preliminary experiments revealed low sensitivity and signal drift in the NEFA 
assay. Because this had not been observed with the glass devices, and it is well-known 
that PDMS can adsorb hydrophobic molecules2.31, 32, the problems with signal were 
attributed to adsorption of the hydrophobic fatty acids by PDMS. A variety of PDMS 
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modifications that might prevent NEFA adsorption, including sol-gels, polyelectrolyte 
multilayers, and dynamic coating with SDS, polyethylene glycol, and Pluronic F-127, 
were tested for their effect on the NEFA signal.2.33-37 The best results, as determined by 
NEFA assay sensitivity and stability, were obtained when the channels were dynamically 
coated with a 20 mM SDS solution.2.38, 39  
For the SDS treatment, it was important that chips were modified a few days after 
fabrication. This ageing effect was attributed to corona discharge used for bonding. 
Corona discharge creates a hydrophilic surface, which slowly reverts back to its native 
hydrophobic state, that would be better able to bind SDS.2.40, 41 The NEFA assay 
sensitivity increased from 7.6 ± 2.5 RFU∙µM-1 (n = 3) to 11.1 ± 2.3 RFU∙µM-1 (n = 3) 
with SDS modification (Figure 2.7). Day-to-day experiments on the same chip modified 
with SDS had reproducible calibration curve slopes with a RSD of 2.1% (n = 3).  The 
coating was refreshed every day to maintain this performance.  
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Figure 2.7: NEFA calibration curves illustrate the improved assay sensitivity with 
daily SDS modification (a). The real-time traces of on-line switching from low to 
high concentration are shown in (b). Assay 1 was performed immediately after SDS 
modification. Assay 2 was run a subsequent day without prior SDS modification, 
and a lower sensitivity is observed. The original sensitivity can be restored; SDS 
modification was done before assay 3 and improved signal is seen. All 3 assays were 
performed on the same chip. 
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To reduce the exposure of fatty acids to the PDMS, a glass coverslip was bonded 
to the top of the cell chamber.  This lessened the surface area that the fatty acids could 
contact the PDMS while in the cell chamber, resulting in a further 44% improvement in 
assay sensitivity. The addition of the coverslip also had the benefit of directing flow 
towards the cells, allowing improved sampling of cell secretion.  
Although these measures improved the sensitivity, we still observed drift in signal 
for the fatty acid assay over time. Addition of the non-ionic surfactant, Triton X-100, to 
CR-A reagent reduced drift of the signal at high standard concentrations so that the RSD 
improved from >12% to 1-5%. This effect may be due to both prevention of adsorption 
and improving enzyme solubility.  
Adipocyte Perfusion 
Representative simultaneous traces of adipocyte secretion of glycerol and NEFAs 
are shown in Figure 2.8a and b. Basal concentrations, i.e. secretion prior to drug 
treatment, were above the LOD of both assays for all cases. Upon addition with 20 µM 
isoproterenol, a drug that stimulates lipolysis, a simultaneous increase in concentration of 
both analytes was observed between 2 and 6-fold depending on the batch of cells used. 
Previous work with static culture systems have reported a 2 to 7-fold increase in lipolysis 
products with a similar stimulation.2.42, 43 The simultaneous measurement of NEFA and 
glycerol allows an assessment of recycling. For example, for the case in Figure 2.8a, the 
NEFA:glycerol ratio was 1:1 implying some recycling that did not change after 
stimulation. In contrast, for the cells used in Figure 2.8b, we observed NEFA:glycerol of 
1:3 that increased to 2:1 with isoproterenol suggesting high recycling that decreased with 
stimulation. Previous studies have reported a wide range of NEFA:glycerol ratios, e.g. 
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from 1:22.44 to 2:12.42 for 3T3-L1 adipocytes. In general values are less than the 
theoretical maximum of 3:1, similar to our results. Few results have been reported on 
NEFA:glycerol ratio for 3T3-L1 cells with isoproterenol treatment; however, studies of 
primary adipocytes have reported that isoproterenol generally evokes higher 
NEFA:glycerol ratios (less recycling) than basal as we observed for most of our trials. 
For example one report showed a 1.3-fold increase in NEFA:glycerol ratio.2.45  
Interestingly, the NEFA:glycerol ratio showed a decreasing trend in adipocytes 
that were cultured for more extensive periods of time (Figure 2.8c). We also observed 
greater responsiveness of NEFA secretion to isoproterenol for longer times after 
induction (Figure 2.8d). The cause and significance of these trends is not known; 
however, the larger secretion of NEFA at longer times could relate to greater lipid 
content as the cells age in culture.  Further studies with this method will be required to 
better understand the significance of such changes. 
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Figure 2.8: Representative traces of simultaneous detection of NEFA and glycerol 
secretion from adipocytes and trends in day-to-day experiments. Traces were 
collected during basal secretion and during lipolysis stimulation by the application 
of isoproterenol, represented by the black bar. (a) Cells day 14 post-induction (PID). 
(b) Cells day 35 post-induction. (c) The NEFA/glycerol ratio decreased for basal 
secretion the longer the adipocytes remained in culture. (d) As the cells matured, the 
ratio of average isoproterenol-stimulated cell response to the average basal response 
increased for the NEFA assay and decreased for the glycerol assay.   
Conclusions 
 In this study, a multilayer PDMS chip was developed for the perfusion of 
adipocytes and analysis of their secreted metabolites. A multiplexed enzyme assay 
network allowed simultaneous detection of glycerol and NEFA concentrations released 
from cultured 3T3-L1 adipocytes. COMSOL modeling aided in the design and 
implementation of the dual, asymmetric assay system. PDMS proved to be a good 
substrate for these experiments following modification of the channels with SDS. Basal 
and stimulated lipolysis conditions were monitored from perfused adipocytes in real time. 
 54 
 
Appropriate stimulation of analyte secretion was observed with the addition of 
isoproterenol. Initial trends imply that there are changes to the biology of 3T3-L1 
adipocytes with time in culture, and could provide more detailed information about 
lipolysis and NEFA recycling. The continuous flow format allows changes in metabolism 
to be monitored within minutes of occurring. The novel microfluidic chip illustrated the 
potential of creating a complete, automated, and reusable analysis system for 
simultaneously monitoring multiple cellular functions. This tool could be extended to 
measure the lipolysis and fatty acid recycling in primary adipocytes and their response to 
different stimuli. Furthermore, principles learned from these experiments, such as split 
assays and SDS modifications for hydrophobic moieties, could be applied to monitoring 
other cell types in lab-on-chip systems.  
Supplementary Information 
To design a simultaneous chip, we first developed single assay chips for glycerol 
and NEFA, based largely on single channel devices reported previously.2.23, 24 For on-line 
assays the following factors must be considered: 1) cell chamber volume should be low to 
allow use of small amounts of cells and reduced reagent costs; 2) flow rates should be 
high enough rapidly wash-out the cell chamber for good temporal resolution but not so 
high as to create excessive pressures that may cause leaks or excessive dilution of the 
chemicals to be measured; 3) reagent channels should allow both rapid mixing and 
enough incubation time for the assays.  
As a starting point for chip design, we initially set the cell chamber volume to 8 
µL, matching the dimensions previously reported.2.24 We estimated that the perfusion 
flow rate should be no higher than 0.75 µL/min to avoid diluting the cell secretions below 
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the detection limit of the assays. Using this flow rate through the chamber, the 
downstream assay reagent inlet flow rates were optimized to provide the best sensitivity 
during calibration experiments. For the NEFA assay, it was determined that a flow of 0.6 
µL/min for the assay reagents provided the optimum sensitivity. Likewise, with the 
glycerol assay, reagent flow rates of 0.75 µL/min were chosen. Because the assays 
require 5 min incubation time, we determined that the reaction channel volume should be 
12.6 µL. A 600 µm wide by 60 µm deep by 350 mm long channel provides the volume 
necessary in a convenient size that does not create much back pressure at the flow rates 
used. In principle other channel dimensions could be used. To aid mixing, we created 
thinner (100 µm), serpentine channel regions after each reagent inlet. 
Through off-line optimization experiments, it was discovered that the mixing 
order and duration was key to improving the NEFA assay sensitivity. The first reaction of 
the assay seems to be rate-limiting, and therefore needs sufficient time to incubate before 
addition of the second reagent and fluorogenic dye. Moreover, CR-B and AUR should be 
introduced in separate inlets, because pre-mixing the reagents increases the background 
of the assay. Therefore, the NEFA channel was altered to position the CR-B and AUR 
reagent inlets downstream after the CR-A reagent was added. Aside from the differences 
in reagent inlet number and location, the chip designs for the 2 independent assay devices 
were nearly identical. The linear calibration curves for both assays are shown in Figure 
2.9. Using the independent chips as guides for developing a chip containing both assays, 
the resulting chip had 2 sets of mixing channels that were symmetrical aside from the 
number and location of reagent inlets. 
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Figure 2.9: Calibration curves for the glycerol (a) and NEFA (b) assays, performed 
on the respective single assay chips. The error bars are the standard deviations of 
the averaged time points. 
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CHAPTER 3   
 
MONITORING CELL SECRETIONS ON MICROFLUIDIC CHIPS USING 
SOLID-PHASE EXTRACTION WITH MASS SPECTROMETRY 
 
Introduction 
 Microfluidics has become an enabling technology for analytical chemistry by 
allowing miniaturization, integration, and automation, often with performance 
enhancements over larger scale instruments. Many examples of performing chemical 
assays or separations on microfluidic chips with impressive sensitivity and throughput 
have been reported.3.1, 2 Microfluidics has also been enabling for cellular biology. Cells 
can be cultured on chips after loading into chambers by flow and other methods.3.3, 4 The 
fluidic environment allows cell culture conditions to be exquisitely controlled and better 
match in vivo conditions.3.4-6 Integrating chemical analysis with culture enables cell 
function to be assayed under different conditions.3.7, 8 Such studies can be critical for 
studying cell physiology. In this work, we describe an approach to integrating living cell 
perfusion on-chips with electrospray ionization mass spectrometry (ESI-MS) to analyze 
secretions from the cells.  
Culturing and monitoring cells on microfluidic chips has many advantages over 
conventional techniques. The inherent size of such devices reduces the number of cells 
required.3.9, 10 Constant perfusion of culture media on chip allows replenishment of 
essential nutrients and removal of waste products, which creates a more physiologically 
relevant environment and provides the capability to change conditions for controlled 
experiments.3.5, 11, 12 It is relatively straightforward to monitor cell function using 
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fluorescence microscopy on chips.3.13-16 Perfusate can also be analyzed by other 
analytical techniques to measure cell secretions and other effects of the cells on chemical 
environment. Several examples of manually sampling perfusate from chips for detection 
of peptide or metabolite release from cells have been reported3.17-20; however, manual 
sampling of perfusate and off-line assay fails to fully to take advantage of the integration 
and automation possible on chips.  
Several studies have reported integration of on-line analysis of perfusates to 
monitor cellular secretions on chips.3.21, 22 Immunoassay3.23-25  or enzyme assay3.26-28 with 
fluorescent detection, capillary electrophoresis with electrochemical detection3.29, and 
enzyme assay with chemiluminescent detection have all been used.3.30 These methods 
give temporal resolution and selectivity in the measurement providing excellent insight 
into cell function. For example, rapid electrophoresis assays have been used to monitor 
insulin secretion in real time from single islets of Langerhans providing information on 
oscillations of secretion.3.31 A commonality of these methods however, is that they are 
specific for a single (or small number) of compounds and new assays must be designed 
for each target analyte.  
To develop a more versatile approach to chemical monitoring of cells on chips, 
we have investigated coupling MS to cell culture chips. MS is a powerful, sensitive, and 
widely available analytical technique. MS also provides high selectivity, the ability to 
detect multiple compounds in single scans, and direct detection of compounds without 
labels. ESI-MS is compatible with continuous flow systems and can be coupled to 
microfluidic chips.3.32-36 All of these properties make ESI-MS well-suited as a general 
tool for analyzing cell perfusates. Combining the many advantages of on-chip cell 
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perfusion and MS detection suggests potential for a powerful approach to study cell 
secretion dynamics.  
Although ESI-MS is well suited for this application, a significant impediment is 
that biological samples often contain high concentrations of salts and other species that 
can cause ion signal suppression in MS.3.37 Sample “clean-up” methods like solid phase 
extraction (SPE) are often used to remove interfering species prior to ESI-MS. SPE can 
be implemented during off-line sample preparation prior to analysis (e.g., ZipTip)3.18 or 
in an on-line format3.33, 37, 38. In SPE, samples are loaded onto a packed bed of sorbent. 
The bed is rinsed to remove poorly retained species, and then a solvent is passed through 
the bed to elute analytes. Hydrophobic sorbents are often used to retain analytes and 
allow removal of salts.   
In previous work, microfluidic cell perfusion has been coupled to on-chip SPE 
and ESI-MS analysis.3.39, 40 These devices were applied to monitor vitamin E metabolites 
secreted from lung epithelial cells3.39 and glutamate release from neuronal cells3.40. This 
seminal work illustrated the potential for such approaches; however, in these reports, the 
components are on separate devices so that the steps of SPE required repeated and 
manual disconnection and reconnection of tubing to the chips. In addition, the cells are in 
direct fluidic connection to the SPE packing and therefore are exposed to higher 
backpressures generated by the bed. This higher (and changing) pressure is potentially 
detrimental to cell viability because high shear stress can cause changes in normal cell 
morphology and function.3.10 Furthermore, increased shear can also cause detachment of 
adhered cells from the surface, which is especially undesirable for buoyant adipocytes. 
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To create an automated, on-line microfluidic cell perfusion system with ESI-MS 
analysis, we have developed a PDMS chip that integrates a cell chamber with an injection 
loop that functions like a conventional 6-port valve. The injection loop allows automated 
collection of perfusate and then injection onto an in-line SPE-ESI-MS system. The 
injection system fluidically isolates cells from the SPE packing to prevent exposing cells 
to changing pressure. The pneumatically-actuated valves were integrated on the PDMS 
chip through multilayer assembly.3.41 In such devices, a ‘control’ channel is overlaid 
across a shallow fluidic channel. When gas pressure is applied through the control 
channel, the fluid channel is constricted via deformation of the elastomeric PDMS to 
block flow. 
Cultured adipocytes are used as a model cell system in this study. Adipose tissue 
is integral to maintaining systemic energy balance by storing and releasing lipids based 
on physiological requirements. Adipocytes secrete non-esterified fatty acids (NEFAs) 
through regulated lipolysis.3.42, 43 Adipocytes represent a particularly challenging cell type 
because they are fragile and buoyant, making them susceptible to changes in pressure or 
shear. In previous reports, NEFAs secreted from perfused adipocytes have been measured 
on PDMS chips with enzyme assays and laser-induced fluorescence.3.26, 28 These enzyme 
assays only allow total NEFA measurement; MS is a more versatile detection technique, 
allowing detection of specific NEFAs. With this chip-MS method, the change in specific 
NEFAs released during lipolysis stimulation could be determined, better indicating the 
composition of circulating NEFAs due to lipolysis than with previous methods. 
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Experimental 
Reagents 
LC-grade acetonitrile (ACN) and water, isoproterenol hydrochloride, forskolin, 
palmitoleic acid standard and fatty acid free bovine serum albumin (BSA) were 
purchased from Sigma-Aldrich (St. Louis, MO). Ammonium hydroxide was obtained 
from Fisher Scientific (Pittsburgh, PA). Cell culture reagents and Hank’s buffered salt 
solution (HBSS, Cat. No. 14175) were received from Life Technologies (Carlsbad, CA).  
PDMS Chip Fabrication 
Chip fabrication used procedures similar to those described before3.28. The 
injection loop chip was composed of two separate pieces and all layers were formed from 
10:1 base:curing agent PDMS (RTV 615, Curbell Plastics, Livonia, MI). Three Si wafers 
with raised features were made using SU-8 2075 photoresist (MicroChem, Newton, MA). 
Wafer A contained the lower cell chamber and was 250 µm thick (mask shown in Figure 
3.1a). Wafer B consisted of the fluidic channels with SU-8 features 60 µm thick and AZ 
9260 (Capitol Scientific, Austin, TX) features 12 µm thick (Figure 3.1b). Wafer C 
contained the SU-8 control channel features that were 60 µm thick (Figure 3.1c). PDMS 
was poured over wafer A and manually spread to create a layer ~1 mm thick. PDMS was 
spun on wafer B to a height of 70 µm. A thick layer (~1 cm) of PDMS was poured over 
wafer C. Additionally, PDMS was spun on a blank wafer to a height of 170 µm. All 
wafers were baked at 80 °C for 1 hr. The PDMS molded from wafer C was peeled off the 
wafer and holes were punched through the PDMS at the green points indicated on Figure 
3.1c. This layer was irreversibly bonded to the PDMS spun on wafer B, feature side 
down, using corona discharge. The bonded layers were peeled away from wafer B and 
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were then bonded, feature side down, to the PDMS spun on the blank wafer. The 3 layers 
(forming the top part of the chip) were peeled away and the bottom layer of PDMS was 
cut away around the cell chamber dimensions. A glass coverslip (No. 1, Fisher Scientific) 
was bonded to the top of the cell chamber. Capillary tubing was used to move fluid in and 
out of the chip. One side of 50 µm inner diameter (ID)/150 µm outer diameter (OD) 
capillaries (Polymicro Technologies, Phoenix, AZ) were rounded with fine sand paper 
and inserted into the sides of the chip. The other end of the capillary was sheathed with 
180/360 capillary and the two capillaries were then permanently secured using 
cyanoacrylate glue. Stainless steel tubing, (23 G, 1 cm long) sheathed halfway with 
Tygon Tubing (1/16 in. OD, 0.5 mm ID, IDEX, Lake Forest, IL), was inserted into the 
aforementioned holes made in the PDMS layer taken from wafer C. The PDMS from 
wafer A was peeled away and bonded to a glass slide, feature side up, forming the bottom 
part of the chip. 
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Figure 3.1: PDMS mold layers. Each box indicates a different fabricated layer; (a) 
lower cell chamber, (b) fluidic layer, and (c) valve control layer. The numbers in (c) 
indicate the valves that are operated together on the same solenoid valve. 
Adipocyte Culture 
Murine 3T3-L1 adipocytes were cultured to day 11-13 post-induction as 
previously described.3.28 Briefly, glass coverslips (No. 1, Fisher Scientific) were cut to 
4.8 mm x 4.8 mm and placed in the bottom of 6-well plates. Preadipocytes were plated 
over the coverslips at a density of 100,000 cells/mL. Two days after the cells reached 
confluence, adipogenesis was induced with 500 µM isobutylmethylxanthine, 1 µM 
dexamethasone, and 1 µg/mL insulin in adipogenic media. Adipogenic media consisted 
of 10% fetal bovine serum (FBS), 1 mM sodium pyruvate, 2 mM L-glutamine, 100 
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units/mL penicillin, and 100 µg/mL streptomycin in Dulbecco’s eagle medium (Cat. No. 
11965, Life Technologies). 2-3 days after induction treatment, the media was replaced 
with adipogenic media containing 1 µg/mL insulin. Every 2-3 days following, fresh 
adipogenic media was added. 
Chip Assembly and Operation 
Prior to each use, the top portion of the PDMS chip was degassed for 30 min and 
the channels and Tygon tubing were primed with water. A coverslip with adhered 
adipocytes was removed from culture, rinsed with basal perfusion buffer (0.1% BSA and 
25 mM glucose in HBSS) and transferred to the lower cell chamber. An additional 10 µL 
basal perfusion buffer was added to the top of the cells and the 2 chip pieces were sealed 
together, using the outline of the cell chamber in both portions for alignment. During 
calibration experiments, the same assembly procedure was used, but with a blank 
coverslip placed in the lower cell chamber. All air and excess liquid was removed 
between the layers. To ensure a leak-free operation, the assembled chip was compressed 
in plastic frame. One side of the compression frame had holes drilled at the same spacing 
as where the PDMS control channel layer was punched. Both pieces had holes drilled 
around the chip dimensions for adding bolts to compress the plastic. The valve Tygon 
tubing was threaded through the compression frame and the chip was lightly tightened in 
the frame. A LabView 12.0 (National Instruments, Austin, TX) script was written to 
operate a series of solenoid valves (LHDA1211111H, The Lee Co., Westbrook, CT), 
which controlled flow from an N2 tank to the Tygon tubing in the chip, similar to that 
described previously.3.44  
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Chip-to-MS Connection 
A suspension of 20 µm fully porous C18 particles (Alltima, Grace Davison, 
Deerfield, IL) was made in methanol (~2 mg/mL). Polished ends of 150/360 and 40/360 
capillary were connected with a PicoClear union (New Objective, Woburn, MA). The 
particle slurry was pushed into the 150/360 capillary using a syringe until the bed length 
was ~1 mm long. The outlet of the injection loop chip was connected to the 150/360 
capillary with a Teflon union as shown in Figure 3.2. The other end of the 40/360 
capillary was inserted into a metal tee which was used to apply voltage for electrospray. 
A spray tip (75/360 capillary with a 15 µm tip, New Objective) was inserted in the 
opposite end of the metal tee (the third port was plugged with an optical fiber). The entire 
assembly was mounted on a platform, built on an x-y-z stage for easier alignment with 
the MS source. 
 
Figure 3.2: Schematic of chip connection to SPE column and ESI components. 
Mass Spectrometry Detection and Analysis 
A triple quadrupole (QQQ) mass spectrometer (TSQ Quantum Ultra, Thermo-
Scientific, Waltham, MA) was used for detection of the NEFA species. The platform 
supporting the chip and connections was inserted through the door of the ion source and 
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the spray tip was positioned ~8 mm from the ion funnel. The spray voltage was kept off 
during the SPE loading phase, but was set at -2.5 kV during the wash and elution steps. 
The ion source capillary was maintained at a temperature of 250 °C and full scan mode 
ranging 200-320 m/z with a scan rate of 2 Hz was used for recording. Peak areas of the 
detected NEFAs were measured with a range of ± 0.5 Da of the [M-H]-. In some cases, 
high resolution time-of-flight MS was used for analysis (see Supporting Information). 
Results and Discussion 
Chip Design & Operation 
This work builds upon a previous chip that was reported to measure NEFA 
secretion from on-chip adipocyte perfusion.3.28 In that work, cell perfusate was mixed on-
chip with enzyme assay reagents in a continuous flow system to allow real-time 
monitoring of NEFA release; however, this method did not allow identification of 
individual NEFAs. With this new PDMS chip (Figure 3.2), it is possible to perfuse cells 
and directly monitor secretion of NEFAs via SPE-ESI-MS. The integration of an 
injection loop on chip enables automated fraction collection and coupling to a SPE-ESI 
capillary without exposing cells to changes in pressure due to flow through the packed 
bed. A square cell chamber design is used on this chip like previously described3.28. 
Chamber inlets were positioned so that buffer flows as a flat front (as opposed to 
parabolic profile) down the length of the chamber which improved the temporal response 
of the system. Approximately 25,000 3T3-L1 adipocytes are loaded into the cell 
chamber. This cell requirement is an ~80-fold reduction compared to conventional cell 
analysis in a 6-well plate, illustrating the potential for miniaturization.  
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Four valves were constructed upstream of the cell chamber to automate selection 
of cell perfusate solution (Figure 3.3). One inlet upstream of the cell chamber was infused 
with basal buffer and the other with 20 µM isoproterenol/10 µM forskolin with 0.1% 
DMSO in basal buffer. (During calibration, different concentrations of standards were 
infused through the inlets). The valves operated so that as one solution flowed to the cell 
chamber, the other flowed to waste. Actuating the valves changed the solution flowing 
over the cells. These solutions had a flow rate of 0.75 µL/min, which was therefore the 
flow rate perfused over the cells. There were a number of tradeoffs when selecting the 
flow rate. A high flow rate would be advantageous for temporal response by decreasing 
the time for each round of injections; however, excessively high flow rate may damage or 
dislodge cells, overly dilute analytes, and cause valves to fail.  
Downstream of the cells, the direction of flow was controlled through the 
switching of 6 multilayer valves (see Figure 3.3), which operated independently of the 4 
valves upstream of the cell chamber. These valves controlled sample collection and SPE. 
In the first step of chip operation, cell perfusate from the cell chamber was directed into a 
serpentine loop, while a wash solvent (10% ACN/90% H2O with 15 mM NH4OH) was 
infused through a side inlet. During loop filling mode, the cell perfusate (sample) was 
directed through the loop to waste at the loop exit, while the wash solvent bypassed the 
loop and flowed directly into the SPE column as illustrated in Figure 3.3a. Once the loop 
was filled, the valves were switched and the sample was pumped onto the SPE bed while 
cell perfusate was directed to waste as shown in Figure 3.3b. The valve was set in this 
position for 12 min to fully load sample and allow rinse of the SPE column with wash 
solvent. Once the sample was fully loaded onto the SPE bed, the valves were switched 
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back to their original position. The wash solvent bypassed the loop and was pumped onto 
the SPE bed for an additional 5 minutes to ensure all the salts were removed from the 
SPE packing. The wash solvent was replaced with the high organic elution solvent (75% 
ACN/25% H2O with 15 mM NH4OH) via an external 4-port valve to elute the NEFAs for 
detection (Figure 3.3c). During the third step, the sample loop was filled with cell 
perfusate in preparation for the next fraction analysis. Using this procedure, 3 assays 
were performed with cells under basal conditions, and another 3 with cells stimulated 
with the isoproterenol/forskolin mixture (each iteration taking a total of 30 min). With 
this isocratic method, the NEFAs were all eluted to the MS at the same time. 
Implementing a gradient elution protocol could allow chromatographic separation of the 
NEFAs and improve their detection.  
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Figure 3.3: Operation modes for the injection loop chip. Closed valves are black and 
open valves are white. (a) Loop fills with perfusate from cell chamber (red) and 
flows to a waste outlet, while the wash solvent (blue) bypasses the loop and is 
directed towards the SPE bed. (b) The cell perfusate is flushed out of the loop and 
onto the SPE bed by the wash solvent. Flow from the cell chamber is directed 
towards a waste outlet upstream of the loop. (c) Valves are in the same mode as (a), 
but wash solvent is replaced with elution solvent (green). Elution solvent bypasses 
the loop and is flowed onto the SPE bed, while the loop fills with cell perfusate 
again. 
Overall, this system operated like a conventional HPLC injection valve coupled 
with a short SPE bed. Integration of the loop allowed fluidic isolation of the cells from 
the downstream elements that could generate back pressures (SPE packing, spray tip). 
The serpentine pattern reduced the footprint of the chip, while providing enough channel 
length to collect adequate sample for MS injection. The injection loop was designed to 
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hold 7.5 µL of sample, so with the flow rate used, it took 10 min to fill/empty the loop. 
The size of this channel could be reduced in future generations of the chip, improving 
temporal response. 
Initial experiments revealed that back pressure of the SPE bed caused control 
channels fail. To prevent this, the 6 valves that operated the injection loop were modified 
so that control channels for each valve were branched to five channels. This branching 
allowed complete channel closure under conditions with downstream backpressure. 
Using inlet flow rates of 0.75 µL/min, the valves remain functional (i.e., completely 
sealed the lower fluid channels) up to back pressures of ~7 psi at the chip outlet. A video 
showing the operation of the multilayer valves is available in the supplementary 
information. This pressure limit, while sufficient for SPE as demonstrated here, 
constitutes a limit of this system for using longer columns or smaller particles. 
The SPE bed was made with 20 µm particles packed into a large bore capillary 
(150 µm ID) to minimize flow resistance. A 40 µm ID capillary at the exit of the SPE bed 
served to hold the particles in the capillary because particles will not flow through this 
capillary once packed due to the keystone effect.3.45 A ~1 mm long SPE bed packed in 
this manner creates about 2.5 psi backpressure at a flow rate of 0.75 µL/min. We also 
explored using glass fiber frits to hold the particles in place3.46; however, we found that 
the back pressure was too high to operate at effective flow rates.  
The spray tip size was another consideration taken into account for this system. 
Smaller tips create more efficient spray, but they were prone to clogs. A capillary that 
had a 75 µm ID, pulled to 15 µm at the tip, provided sufficient spray (with low back 
pressure) and was able to be used for routine experiments without clogging.  
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Chip Characterization 
 To determine the reproducibility of injections using the chip, a 50 µM standard of 
palmitoleic acid (16:1, [M-H]- = 253.2 Da) was perfused through the cell chamber, filled 
the loop, loaded onto the SPE bed and eluted to the MS repeatedly. It was found that the 
average peak area of 5 replicate injections was 5.8 ± 0.41 x 1010 (8% RSD). The average 
peak width was 50 s, indicating 12x sample concentration on the SPE bed (10 min load 
time). Similarly, to demonstrate the potential for quantification of NEFAs by chip-MS, a 
calibration curve of palmitoleic acid standards was created, shown in Figure 3.4. With 
standards measured in duplicate, the calibration curve had a R2 of 0.98. The limit of 
detection for palmitoleic acid was 1.4 µM, as determined by the concentration of the 
signal that was 3 times the standard deviation of the two blank injections. This 
performance is not as good as might be expected for on-line SPE using a conventional 
HPLC valve and SPE bed, but such an instrument would be less integrated than the 
design described here. Furthermore, the analytical figures of merit for this chip are 
adequate for many physiological studies. 
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Figure 3.4: Calibration curve of palmitoleic acid (POA) standard, performed in 
duplicate. POA was dissolved in basal buffer and perfused through the chip at the 
inlet upstream of the cell chamber. Standard filled the loop, was loaded onto the 
SPE bed, washed and eluted to the MS in an on-line format. 
NEFA Detection 
 Using the injection loop chip, select NEFAs secreted by adipocytes were analyzed 
by coupling on-chip cell perfusion to ESI-MS. Negative ion mode ESI was used for 
NEFA detection as the preferred ionization mechanism for NEFAs is the removal of a 
proton from the acidic carboxyl group.3.47 All experiments were performed with 
adipocytes under basal conditions, followed by the perfusion of solutions containing 
isoproterenol and forskolin to stimulate lipolysis.  
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Initial experiments were aimed at evaluating what compounds were detected. 
Figure 3.5 shows a mass spectrum collected from the cells on chip compared to 
background. For this data, the mass spectrometer was scanned from 200 to 320 m/z 
comprising the range of the most common NEFAs. To determine the source of the 
signals, we matched the signal to m/z values for NEFAs known to be present in 3T3-L1 
adipocytes. Previous work using GC-MS has shown that NEFAs from C8 to C20, both 
saturated and monounsaturated, are present in adipocytes with C14-C18 being the most 
prevalent. In agreement with those findings, we found peaks matching the nominal mass 
of C14:0, C15:1, C15:0, C16:1, C16:0, C17:1, C17:0, C18:1, C18:0, and C20:4. Small 
peaks for C16:0 and C18:0 were also found in background signals and therefore not 
further investigated. (Previous studies have also reported background signal from 16:0 
and 18:0 in fresh LC solvents).3.48 To better verify the identity of the signals, we also 
analyzed cell conditioned media by HPLC-TOF-MS (see supplemental). We found 
matching peaks for all of the NEFAs detected from the chip system but at the higher mass 
accuracy (as low as 1 ppm) of the TOF-MS. These results and matching what was found 
in the prior GC-MS studies, provide better confidence in the identifications shown in 
Figure 3.5. Collision-induced dissociation (CID), a fragmentation method used to more 
accurately identify compounds, was attempted but did not prove successful with the 
native NEFAs of interest in our study or in other reports.3.49 
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Figure 3.5: Full scan analysis of m/z ranging from 200-320 was performed for all 
experiments on a QQQ-MS. (a) Mass spectrum of on-line elution profile from 3T3-
L1 adipocytes. Adipocytes were loaded in the cell chamber and stimulated with 
isoproterenol/forskolin in this example spectrum. Perfusate was loaded onto the on-
line SPE bed. The SPE bed was subsequently washed and sample was eluted to the 
MS. Peaks are labeled with the NEFAs that associate with the appropriate m/z. (b) 
Mass spectrum of direct injection of elution buffer, showing background signal of 
16:0 and 18:0. 
We then used the chip to monitor the effect of treatment with 
forskolin/isoproterenol on NEFA secretion (Figure 3.6). These agents are known to 
stimulate lipolysis and evoke release of NEFA from adipocytes. To measure the various 
NEFAs, the peak areas of the extracted ion chromatograms (EICs) were calculated at the 
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expected m/z of the NEFAs.  This is the first MS study for measurement of secreted 
NEFAs from living, perfused adipocytes. Stimulation of lipolysis with forskolin or 
isoproterenol generally results in a 2- to 10-fold increase in NEFA secretion over basal 
conditions as measured by enzyme assay in static culture or on-chip perfusion.3.26, 28, 50-52 
As shown in Figure 3.6, a statistically significant increase in 7 NEFAs was found with 
the application of lipolysis stimulating agents. The increase measured with the MS 
detection method was 1.2- to 1.9-fold over basal levels. This increase in less than what 
has been detected using enzyme assays for all NEFAs.3.28 The smaller magnitude of 
stimulation detected with this technique could be accounted for by the fact that the 
enzyme assays measure every NEFA released from the adipocytes, while with the current 
method, two of the most abundant NEFAs were not able to be accurately detected. 
Furthermore, the relative abundance of secreted NEFAs could vary depending on culture 
conditions (i.e. the types of NEFAs present in a FBS aliquot, which is the source of lipid 
accumulation in cultured 3T3-L1 adipocytes). 
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Figure 3.6: Averaged peak area of various NEFAs detected by MS from on-chip 
adipocyte secretion under basal and isoproterenol/forskolin (iso/fsk) stimulation. 
Data is average of 3 cell experimental replicates ± standard deviation, statistical 
significance determined by paired, 2-tailed Student’s t-test, * P < 0.1, ** P < 0.05, 
*** P < 0.01. 
Conclusions 
 An integrated microfluidic chip has been developed that is capable of perfusing 
cultured cells and monitoring secreted metabolites with MS detection. This continuous 
flow device allows cells to be cultured under physiologically-relevant conditions while 
coupling to MS enables potential detection of a wide variety of secreted metabolites. 
PDMS as the microfluidic substrate enable multilayer valve construction, similar to 
conventional 4- or 6-port valves, increasing the automation of analysis. The injection 
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loop valve system allowed discrete volumes of sample to be loaded onto an SPE bed, 
while isolating the cells from the backpressure generated by downstream clean-up or 
separation techniques. Using adipocytes as a model cell system, a variety of NEFAs were 
detected with this on-line perfusion format. NEFA secretion was measured under basal 
and stimulated conditions, demonstrating the capability of performing a range of 
biologically significant experiments on cultured cell lines on one miniaturized platform.  
Although NEFA secretion was measured from adipocytes, this basic system 
could, in principle, be used for measuring release of other secretions from other cell 
types. The advantage of the MS system, compared to enzyme and immunoassay 
previously used for monitoring cell secretion on chips, is the versatility to detect a wide 
variety of compounds. Further, the ability to detect multiple compounds with a rapid scan 
enables multi-analyte monitoring. In the current system, a perfusate was collected in a 
loop and then extracted by SPE. The integration of SPE enables removal of ion 
suppressing components and concentrates the analytes 12x for greatly improved 
sensitivity of ESI-MS. Indeed, the NEFAs would not be detectable at the flow rates used 
without SPE. A weakness of the system as described here is the low temporal resolution 
for monitoring (30 min to fill loop and elute one sample). Chips with other materials may 
allow higher pressures to be used to increase flow rate over the SPE bed. Alternatively, 
other on-line extraction methods might prove useful.  
Supplementary Information 
Pilot NEFA-MS Studies 
 Initial studies of NEFA secretion from 3T3-L1 adipocytes were analyzed by 
HPLC-TOF-MS. Media from wells of incubated adipocytes was collected and samples 
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were injected onto a reversed-phase column (with a SPE guard column). Samples 
underwent a gradient elution to the MS, from water with 0.1% formic acid to ACN with 
0.1% formic acid. The extracted ion chromatogram (with the mass spectra of select 
NEFAs) using the TOF is shown in Figure 3.7. The measured masses of the various 
detected NEFAs are shown in Table 2, and are compared to those measured with the 
QQQ interfaced to the chip. TOF mass analyzers have greater mass accuracy than QQQ, 
allowing more conclusive identification.3.53 With the QQQ instrument, extracted ion 
chromatograms with mass ranges of ± 0.5 Da of the exact [M-H]- were generated to 
account for the decreased mass accuracy of the instrument. 
 
Table 2: Comparison of measured NEFA mass accuracy on TOF and QQQ. 
NEFA Exact (M-H)- 
TOF QQQ 
Measured Error (ppm) Measured Error (ppm) 
14:0 227.200 227.197 13.2 227.02 792.3 
15:1 239.202 239.205 12.5 238.92 1178.9 
15:0 241.218 241.210 33.2 241.02 820.8 
16:1 253.217 253.218 3.9 252.93 1133.4 
17:1 267.233 267.234 3.7 266.93 1133.8 
17:0 269.246 269.212 126.3 269.03 802.2 
18:1 281.249 281.250 3.6 281.07 636.4 
20:4 303.232 303.228 13.2 303.05 600.2 
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Figure 3.7: Extracted ion chromatogram of 8 NEFAs in adipocyte conditioned 
buffer, measured with HPLC-TOF-MS (a) along with the associated mass spectra of 
the most abundant NEFAs (b). 
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CHAPTER 4  
 
MICROFLUIDIC DUAL ASSAY CHIP FOR MONITORING ADIPOCYTE 
LIPOLYSIS PRODUCTS 
 
Introduction 
 Microfluidics has become a valuable tool for culturing cells and analyzing their 
biological processes. The miniaturized microenvironment of microfluidic devices is ideal 
for the scale of cells, with chambers on the order of microliters in volume.4.1, 2 Therefore, 
fewer cells and reagents are necessary for experiments, reducing consumption compared 
to traditional techniques and potentially enabling studies with rare cells. Constant 
perfusion of cells on-chip creates a setting more closely resembling that of the in vivo 
framework.4.3 Continual flow allows replenishment of nutrients and removal of secreted 
products. Harnessing this inherent aspect of flow, analysis of released metabolites from 
living cells can be performed in a real time.4.4-6 Methods have demonstrated fraction 
collection from perfusion chambers that provide more temporal information than static 
sampling.4.7, 8 Integration of an analysis system on the same microfluidic platform is 
possible and can greatly improve the automation capacity and the understanding of 
cellular dynamics.4.9, 10 
For many cell types it is critical to be able to supply the appropriate stimuli to 
maintain their inherent physiology. These stimuli can range from nutrient content to 
mechanical expansion, but often need to be applied in a repetitive, recurring fashion. This 
was initially demonstrated on large volume perfusion columns. In one example, glucose 
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production from rat hepatocytes was greater when repeated glucagon injections were 
administered in comparison to constant perfusion of glucagon.4.11 It is more difficult to 
automate and precisely control stimuli dispensing on discrete timescales in the 
macroscale, therefore microfluidic devices have been employed to administer delivery of 
a chemical stimulus. This was exemplified with yeast cells; glucose was applied to the 
cells in pulses of varying frequency to monitor gene expression.4.12 Beyond being able to 
maintain proper cell function, it is also of great interest to enable temporally-controlled 
delivery of hormones or drugs to gain further understanding of cellular pathways or to 
develop new disease treatments.4.10 
 Discrete delivery of chemical treatments on microfluidic devices can be 
accomplished through valving of perfused solutions, either on external tubing4.13 or 
integrated on-chip4.14, 15. Polydimethyl siloxane (PDMS) is a commonly used substrate 
for cell-on-chip experiments because it is biocompatible and gas permeable. It also is 
inherently elastomeric, allowing pressure driven valves to be constructed in multilayer 
PDMS devices. Pressure application to a channel will cause it to expand and if properly 
aligned over a fluidic channel in a lower layer, the flow in the fluidic layer can be 
regulated.4.16 Similarly, Braille networks have been implemented on PDMS channels; 
mechanical pressure from plastic pins can constrict a channel.4.17 
Due to the increased population with obesity-related disorders like type 2 
diabetes, it has become increasingly important to understand the inherent pathways and 
mechanisms of adipose tissue.4.18, 19 Adipocytes play a key role in maintaining overall 
homeostasis through the regulation of energy distribution.4.20 A central metabolic process 
in adipocytes is lipolysis; the breakdown of triglyceride molecules into glycerol and non-
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esterified fatty acids (NEFAs). While this process results in a 3:1 breakdown of 
NEFA:glycerol from the original lipid, a percentage of the NEFAs are immediately re-
esterified back into triglyceride molecules.4.21-23 These processes are highly regulated by 
a wide variety of naturally occurring hormones and signaling molecules, and 
pharmaceutical drugs that either promote or inhibit lipolysis and NEFA recycling (eg. 
insulin, glucagon, leptin, catecholamines, glucocorticoids, thiazolidinediones, etc.).4.24-26 
Understanding time dependent roles that these agents play on adipocytes could be crucial 
to extending our knowledge of the regulation of lipolysis. 
 Adipocyte secretions have been examined in vitro under different chemical 
stimuli in static culture. Most reports involve cell incubation with chemical agents on the 
order of hours, which is beneficial for monitoring long term response to a drug.4.27 One 
report measured protein phosphorylation in adipocytes under different durations (as short 
as 5 min) of insulin stimulation by LC-MS.4.28 Microfluidic applications have the 
potential to explore adipocyte response to different stimuli on even shorter time scales 
and with the direct integration of analysis techniques to allow real time monitoring. At 
present however, little is known about the rapid, dynamic responses of adipocytes. 
We previously described a novel microfluidic device that integrated on-chip 
perfusion of 3T3-L1 adipocytes with enzyme assay reaction channels for directly 
monitoring the secretion of glycerol and NEFAs.4.29 The PDMS microfluidic chip was 
designed with a multilayer construction to allow fabrication of pneumatically-actuated 
valves upstream of the cell chamber. These valves can be used to administer different 
chemical stimuli to the adipocytes. The report monitored glycerol and NEFA secretion 
under basal conditions; then the valves were switched to supply an isoproterenol (β-
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adrenergic agonist) solution for the duration of the experiment (30-60 min). This 
continuous application of isoproterenol resulted in a rapid increase in secretion of both 
analytes followed by a sustained elevated release over basal levels. These experiments 
were replicated, and results from this on-chip adipocyte perfusion were compared to 
static incubation of cells (and off-line assay/detection) to monitor variations in NEFA 
recycling between the two techniques. Additionally, to demonstrate a novel utility of this 
chip, short injections of isoproterenol were applied to test the adipocyte lipolytic response 
and determine whether there is a temporal threshold for glycerol and NEFA stimulation, 
something not possible to accomplish with static culture.  
Experimental 
Reagents 
Hanks buffered salt solution (HBSS, Cat. No. 14175), Amplex UltraRed and cell 
culture reagents were purchased from Life Technologies (Carlsbad, CA). Isoproterenol 
hydrochloride, sodium dodecyl sulfate (SDS), fatty acid-free bovine serum albumin 
(BSA), dimethylsulfoxide (DMSO) and glycerol assay reagents were received from 
Sigma-Aldrich (St. Louis, MO). NEFA assay reagents were purchased from Wako 
Chemicals USA, Inc. (Richmond, VA). Triton X-100 was received from Bio-Rad 
Laboratories (Hercules, CA). PDMS was obtained from Curbell Plastics, Inc. (Livonia, 
MI). 18.0 MΩ/cm distilled water was used for making aqueous solutions and flushing the 
chip. 
Adipocyte Culture 
 Coverslips (No. 1, Fisher Scientific, Waltham, MA) were cut to 4.8 mm x 4.8 mm 
with a dicing saw and sterilized with 70% ethanol. The dried coverslips were placed in 
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the bottom of 6-well plates (3-4 per well). Murine 3T3-L1 preadipocytes were seeded in 
the plate at a density of 200,000 cells/well. Cells were cultured in preadipocyte media 
until 2 days post confluence, when they were induced for adipogenesis. Preadipocyte 
media was made of DMEM (Cat. No. 11965-092, Life Technologies) with 8% bovine 
calf serum, 100 units/mL penicillin, 100 µg/mL streptomycin, 2 mM L-glutamine, and 1 
mM sodium pyruvate. Induction was done by adding 500 µM isobutylmethylxanthine, 1 
µM dexamethasone, and 5 µg/mL insulin to adipocyte media. Adipocyte media was the 
same as preadipocyte media, but the bovine calf serum was replaced with 10% fetal 
bovine serum. 2 days after induction, media on the cells was replaced with adipocyte 
media with 5 µg/mL insulin. Media was replaced with fresh adipocyte media every 2-3 
days thereafter. Adipocytes were maintained in an incubator with 10% CO2 until 9 days 
after induction; they were then moved to an incubator supplying 5% CO2. 
PDMS Chip Fabrication 
The fabrication procedures and chip operation were similar to that described in 
Chapter 2. Three PDMS casting molds were made on silicon wafers (University Wafer, 
Boston, MA). The features shown in black in Figure 2.1a-c were made using SU-8 2075 
(MicroChem, Newton, MA), each on a separate wafer. The features in Figure 2.1a & b 
were 60 µm tall (the control and fluidic channels, respectively), and 250 µm tall for the 
design shown in Figure 2.1c (the lower cell chamber). Additionally, the red features 
shown in Figure 2.1b were made 12 µm tall on the respective wafer using AZ-9260 
(Capitol Scientific, Austin, TX) photoresist over the SU-8 mold. The AZ channels were 
rounded by heating to 125 °C for 5 minutes. PDMS pre-polymer was made in a 10:1 ratio 
of base polymer to curing agent, and degassed in a vacuum chamber. The PDMS was 
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poured over the wafer containing the control channels to a height of ~1 cm, spun onto the 
wafer containing the fluidic channels to a height of ~60 µm, and poured over the lower 
cell chamber wafer to a height of ~1 mm. PDMS was also spun onto a blank Si wafer to a 
height of ~170 µm. All PDMS was cured at 80 °C, 5-60 min, with the thicker layers 
requiring longer times.  
The PDMS from the control channel layer was peeled from the wafer and holes 
were punched through at the points shown in blue in Figure 2.1a using a 20-gauge blunt 
needle (Small Parts, Logansport, IN). The side containing the features was exposed to 
corona discharge, as was the top of the PDMS of the fluidic channels (side without 
features). After heating for 10 minutes at 80 °C, the bonded layers were peeled off the 
wafer. Likewise, the bonded piece of PDMS was exposed to corona discharge on the side 
with the fluidic channel features, along with the non-feature side of the PDMS spun on 
the blank wafer. These 3 bonded layers were heated for 10 minutes at 80 °C, and then 
peeled away from the wafer. Using a sharp scalpel, the lower layer of PDMS (originally 
spun on the blank wafer) was removed from the square, upper cell chamber region. A 4.8 
mm x 4.8 mm glass coverslip (No. 1, Fisher Scientific) was bonded in the area where the 
PDMS was just removed. These 3 bonded layers of PDMS made the top portion of the 
reversibly-sealed chip. To form the lower portion of the chip, a glass slide (0.55 mm 
thick; Telic, Valencia, CA) was irreversibly bonded to the feature-less side of the lower 
cell chamber PDMS (making feature exposed) using corona discharge. 
Chip-to-world connections were made using fused silica capillary (Polymicro 
Technologies, Phoenix, AZ) which were inserted into the sided of the top PDMS chip, 
between the fluidic channel and the blank layer. About 15 cm of 50 µm inner 
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diameter/150 µm outer diameter capillary was sheathed at one end with ~2.5 cm 180/360 
capillary, using cyanoacrylate glue to seal together. The opposite end of the 50/150 
capillary was rounded using fine sand paper. This was repeated, making capillaries for all 
7 inlets and 4 outlets. Additionally, tubing connects were necessary to operate the valves. 
Stainless steel pins, cut to ~1.5 cm from 23-gauge tubing, were inserted halfway into 
Tygon tubing (1/16 in. OD, 0.5 mm ID; IDEX, Lake Forest, IL). The other end of the pin 
was inserted into the top PDMS chip, where holes were punched into the control channel 
layer before assembly. The Tygon tubing ultimately connected to a N2 gas tank; the 15 
psi of gas pressure it supplied was operated using a series of solenoid valves 
(LHDA1211111H, The Lee Co., Westbrook, CT), controlled with an in-house designed 
LabView program (National Instruments, Austin, TX). 
Chip Assembly and Perfusion 
Prior to chip assembly, 20 mM SDS was pumped through the 2 chip outlets for 45 
min at 1.5 µL/min. The channels were then flushed with water at the same flow rate for 
20 min. The chip was degassed in a vacuum chamber for ~1 hr. All capillaries, tubing 
and channels were then primed with water. To calibrate the chip (done between every 2 
experiments), a blank 4.8 mm x 4.8 mm coverslip was placed in the lower cell chamber 
and was covered with ~10 µL perfusion buffer (HBSS + 2% (w/v) BSA). The 2 parts of 
the chip were sealed together, aligning using the square dimensions of the top and bottom 
cell chamber, and all air and liquid was squeezed out from between the layers. To ensure 
a leak proof seal, the chip was enclosed with an in-house built plastic compression frame. 
The compression frame consisted of 2 pieces of acrylic plastic, with holes drilled in them 
for screws to tighten the pieces around the chip. Additionally, there were holes drilled in 
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the top piece of the compression frame for valve tubing access, and in the bottom to 
allow closer contact of the fluorescent microscope optics.  
Once assembled, the chip was placed on the stage of the inverted microscope. All 
solutions were made in the aforementioned perfusion buffer. The blank and the lowest 
concentration standard solution were connected to the valve inlets 1 and 2, respectively, 
as shown in Figure 1, and perfused at 0.75 µL/min. The valves were engaged, with the 
blank solution flowed through the cell chamber and the standard solution flowed to waste 
2. Additional 17 cm of 100/360 capillary was added to the valve waste outlets to stabilize 
the flow switching, as described in Chapter 2. Assay reagents were connected to the 
respective inlets shown in Figure 4.1. Reagents on the glycerol and NEFA sides were set 
to flow rates of 0.29 and 0.30 µL/min, respectively. The 1 mM Amplex UltraRed was 
made in 35% DMSO. The glycerol and NEFA reagent B solutions were made per 
manufacturer’s directions. The NEFA reagent A was make 1.66x more concentrated than 
manufacturer’s directions, and the final solution perfused onto the chip was a 4:1 mix of 
concentrated NEFA reagent A to 10% Triton X-100. After the blank assay signal was 
detected, the valves were switched to the first standard solution flowing through the chip. 
The blank solution, flowed towards waste 1, was replaced with the next standard solution. 
Increasing concentration standard solutions were added to the chip in this manner to 
make a complete calibration curve. During cell experiments, only a few changes were 
made: a coverslip with ~25,000 adhered 3T3-L1 adipocytes was placed in the lower cell 
chamber before assembly, and instead of a standard solution flowing through valve inlet 
2, a solution of 20 µM isoproterenol was perfused. 
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Figure 4.1: Overview of microfluidic chip design. Arrows indicate inlet and outlet 
channels, with the respective reagents flowing through each. 
LIF Detection 
  An Olympus IX71 inverted fluorescence microscope was used for detection. A 
10x, 0.40 numerical aperture was used along with the appropriate filters for resorufin 
detection. To image both outlets simultaneously, a Hamamatsu ImagEM X2 CCD camera 
was used. The lamp provided 250 ms light exposure intervals, and data was recorded at 2 
Hz. Data was processed with ImageJ and Microsoft Excel. 
Off-line Adipocyte Incubation, Enzyme Assay & Detection 
 Wells in a 96-well plate (Corning Life Sciences, Corning, NY) were filled with 70 
µL basal perfusion buffer with or without 20 µM isoproterenol. Coverslips with adherent 
3T3-L1 adipocytes were washed with basal buffer, placed in wells and incubated for 40 
min. Triplicate sampling from each well was performed to run off-line assays for NEFA 
and glycerol concentration. For the glycerol assay, 10 µL standard (in basal buffer) or 
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sample was mixed with 6.5 µL 10 mM Amplex UltraRed (stock made in DMSO) and 90 
µL glycerol reagent. Assay solutions were vortexed and incubated for 5 minutes at room 
temperature. To measure NEFA concentration, 10 µL standard or sample was mixed with 
50 µL 1.66x concentrated NEFA reagent A, vortexed and incubated for 5 minutes at 
room temperature. To the solution was added 7.5 µL 10 mM Amplex UltraRed and 25 
µL NEFA reagent B, which was then vortexed and incubated for 5 minutes at room 
temperature. Solutions from both assays were plated in low volume 384-well plates (20 
µL/well in triplicate). Fluorescence detection was performed in a Perkin Elmer Fusion 
(Waltham, MA) plate reader, with excitation and emission filters used for resorufin 
detection. 
Results & Discussion 
Comparison of Off-line to On-line Analysis 
 In addition to differences in automation and scale between conventional 
culture/sampling and microfluidic techniques, there is a difference in the type of 
environment that the cells are exposed to in static and perfused conditions. Perfusion 
systems continually replenish the media cells are exposed to, both providing a constant 
supply of nutrients and removing secreted products. In static culture, cells gradually 
consume the nutrients in the media, resulting in a varying concentration of available 
nutrients over time. Furthermore, secreted cellular products can act as signaling 
molecules on the surrounding cells, potentially changing their response. This effect can 
be observed in adipose tissue. Excess NEFAs in the surrounding environment acts to 
inhibit lipolysis and increase NEFA recycling4.22, whereas circulation can elicit NEFA 
release4.30. 
 98 
 
 The off-line incubation of cells was performed on adipocytes grown on coverslips 
and in smaller wells in an effort to be more consistent with microfluidic observations. As 
described in Chapter 2, a multilayer PDMS chip allowed on-line simultaneous monitoring 
of NEFA and glycerol release from perfused adipocytes. Using averaged NEFA re-
esterification as a comparison between on-line and off-line analysis methods, the basal 
and isoproterenol-stimulated NEFA/glycerol ratios are lower in the off-line analysis, as 
shown in Figure 4.2. The lower ratio indicates that there is more NEFA recycling in 
comparison to the on-line, microfluidic method. This result seems to follow the 
hypothesis that with continuous flow, more NEFAs will be detected, as they are less 
available to be re-esterified immediately by the adipocytes and act as a negative feedback 
signaler.  
As expected, the NEFA/glycerol ratio increases with the application of 
isoproterenol (over basal).4.7 Reports of NEFA recycling of 3T3-L1 adipocytes in control 
static culture experiments demonstrate basal ratios of 0.5:14.31 to 2:14.32 and isoproterenol 
ratios of 1.3:14.33 to 2.5:14.32. As plotted in Figure 4.2, a NEFA/glycerol ratio of 0.5:1 was 
observed with basal buffer and 1:1 with isoproterenol application from off-line sampling. 
While there might be slight variation in sampling techniques between reports, there is still 
a wide range in NEFA recycling values reported. Using a large volume perfusion column, 
Getty-Kaushik et al. reported NEFA/glycerol ratios of 1.39:1 with basal media and 1.80:1 
with 1 µM isoproterenol stimulation from primary rat adipocytes.4.7 The differences 
between adipocyte microenvironment during lipolysis sampling will have to be 
investigated further to reliably understand the changes that occur with the continuous 
flow, microfluidic method. 
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Interestingly, the NEFA/glycerol ratio increases about the same fold change for 
both on-line and off-line methods (1.6- vs. 1.7-fold, respectively) with the application of 
isoproterenol, indicating a similar NEFA recycling response with lipolysis stimulation, 
regardless of circulating conditions. This suggests that the concentration of isoproterenol 
(20 µM) supplied in static culture over the incubation period studied is sufficient to elicit 
a response similar to constant application of isoproterenol, as accomplished with 
microfluidics. 
 
Figure 4.2: Basal and isoproterenol-stimulated (ISO) measurements plotted as a 
function of NEFA/GLY release from 3T3-L1 adipocytes. Statistical significance 
determined by paired (between BASAL and ISO for each technique) or unpaired 
(between bars of the same color) Student’s t-test. * P < 0.01, ** P < 0.0001, n = 10. 
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Short Lipolysis Stimulation 
 With the integration of the multilayer valves upstream of the cell chamber, it was 
possible to have automated switching of perfused solutions that were directed to the 
chamber. In Chapter 2, it was observed that with sustained application of isoproterenol 
resulted in an immediate and continuously elevated concentration of release over basal 
levels. In an initial experiment, cells were stimulated for 30+ min as done in Chapter 2, 
and the valves were switched back to apply blank buffer to the adipocytes. The lipolysis 
products remained elevated over another 30 min period indicating that lipolysis continues 
even in the absence of the stimulus. The isoproterenol stimulation period was then 
decreased to 6 min. The NEFA and glycerol secretion increased, but as opposed to the 30 
min stimulation, it then began to decline when switched back to basal buffer. However, 
analyte concentrations remained elevated over basal concentrations for an additional 60 
min as illustrated in Figure 4.3a. 
In an effort to determine if there was an isoproterenol stimulation time that would 
result in a reversible NEFA and glycerol secretion response, the adipocyte stimulation 
time was decreased to 50 s. As shown in Figure 4.3b, after the initial, rapid increase in 
concentration for both NEFA and glycerol, the concentrations of both analytes return to 
the initial basal levels. Furthermore, it was investigated whether this response could be 
duplicated within the same run (i.e. continuing to perfuse the same group of adipocytes). 
Figure 4.3b shows that a second stimulation of 60 s resulted in a similar effect; the 
second stimulated NEFA concentration was slightly lower than during the first 
stimulation, but the concentrations of NEFAs and glycerol return to basal concentrations. 
Moreover, the relative ratios of NEFA to glycerol remained consistent between the 2 
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stimulations, implying identical changes in NEFA recycling. A basal ratio of 1:1 and 
stimulated ratio of ~2:1 NEFA:glycerol was observed in both runs.  
 
Figure 4.3: Simultaneous detection of NEFA and glycerol (GLY) release from 3T3-
L1 adipocytes. Cells are perfused with basal buffer and then stimulated with 20 µM 
isoproterenol as indicated by the black bar. (a) Isoproterenol stimulation of 6 min. 
(b) Isoproterenol stimulation of 50 s and 60 s in the same experiment. 
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The pathway of isoproterenol stimulation has been thoroughly investigated in 
literature; however, these experiments could offer more insight into the kinetics of 
isoproterenol (or other chemical) stimulation on adipocytes. It is well understood that β-
adrenergic agonist exposure initiates the lipolytic cascade by 1) activating adenylyl 
cyclase which 2) increases cellular AMP levels and 3) activates protein kinase A, that 
then 4) phosphorylates lipid droplet-bound protein, perilipin (PLIN), and hormone 
sensitive lipase (HSL), shown in Figure 4.4a.4.24, 34 Additionally, that phosphorylation 
allows another protein, CGI-58 to activate adipose triglyceride lipase (ATGL). From our 
initial findings it is interesting that there would be differences in lipolytic response with 
acute and prolonged isoproterenol exposure. It would appear that there is a threshold for 
duration of β-adrenergic agonist application before the stimulation is irreversible. It is 
possible that acute isoproterenol exposure only allows a certain percentage of the PLIN 
or HSL to be phosphorylated, whereas more are during prolonged exposure. As 
illustrated in Figure 4.4b, it has also been suggested that a protein, G0S2, acts to 
modulate ATGL activation under acute adrenergic agonist exposure, however degrades 
upon chronic exposure, allowing continually elevated lipolysis to occur.4.24 Degradation 
of a lipolysis inhibitor like G0S2 could be the reason that it is observed that NEFA and 
glycerol concentrations cannot revert back to basal levels after prolonged stimulation. 
Further investigations of this type of lipolysis stimulation kinetics will help elucidate 
adipocyte metabolism. 
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Figure 4.4: Mechanisms of adipocyte lipolysis: pathway of stimulated lipolysis by an 
adrenergic agonist (a) and possible variations in protein action with acute or 
prolonged stimulation (b). Adapted with permission from BioScientifica Ltd.4.24 
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Conclusions 
This multilayer PDMS chip allows a unique demonstration of microfluidic 
devices having the potential to both deliver very short chemical stimuli and ability to 
record response in near real time, without any manual involvement. Comparisons in 
adipocyte secretion of glycerol and NEFAs between conventional static culture and 
microfluidic perfusion platforms were demonstrated. While more experiments are 
needed, this is further evidence that culturing and perfusing cells in microfluidic devices 
could create an environment more closely resembling in vivo dynamics. Further, it was 
found that 50-60 s of lipolysis stimulation with isoproterenol causes the appropriate 
increase in NEFA and glycerol secretion, but then slowly returns to basal concentrations 
over the following 50 min. 
Isoproterenol is often used as a positive control for static adipocyte experiments, 
to ensure proper lipolytic response. Therefore, it was of interest to determine if it could 
be used for the same purpose on-chip within the same experiment. If the concentration of 
NEFAs and glycerol could return back to basal levels after initial stimulation with 
isoproterenol, a subsequent stimulus of interest could be applied to monitor changes in 
lipolysis. Additionally, the kinetics of subsequent stimuli could be tested with this 
integrated PDMS chip to learn more about factors affecting adipocyte function. The 
integrated valves on the PDMS chip allowed automated and rapid switching of cell 
perfusion buffer, making these short stimulation experiments possible. Similar studies 
could also be performed on other cell lines, adjusting the downstream flow network the 
desired chemical assay, allowing valuable insight into the physiology of many different 
tissues. 
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CHAPTER 5  
 
DISSERTATION SUMMARY 
 
In this thesis, fabrication and operation procedures of 2 novel PDMS chips have 
been detailed along with their preliminary applications to understanding secretion 
dynamics of lipolysis products from adipocytes. Microfluidic devices have the capability 
to miniaturize, automate and integrate many analysis techniques. With the addition of cell 
perfusion on chip, conditions mimicking the in vivo environment can be achieved. On-
line detection of secreted metabolites from cells can be accomplished through integration 
on microfluidic chips, reducing sample handling and allowing more temporal information 
to be gathered. 
The chip described in Chapter 2 was developed for multiplexed detection of 2 
secreted products from a continuously perfused group of cells.5.1 This was the first 
demonstration of a chip with this capability. By simultaneously monitoring both NEFAs 
and glycerol secreted from 3T3-L1 adipocytes, more information about cellular 
metabolism and lipolysis can be determined than if the analytes are measured separately. 
The measured quantities of glycerol signify the rate of lipolysis, whereas the 
concentration of secreted NEFAs can imply the amount of NEFA re-esterification 
occurring under particular conditions. Simultaneous measurement was accomplished on 
chip by integrating a flow split after the adipocyte perfusion chamber; media from the 
same temporal domain could be sampled for different analytes. The channels from the 
flow split were directed towards either a NEFA or glycerol fluorescently-modified 
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enzyme assay network where reactions with reagents added downstream occurred. The 
outlets of the 2 channel networks were closely spaced, so the fluorescent product in both 
channels could be imaged together. This chip greatly reduced cell requirements and 
increased automation of sampling and analysis compared to conventional static sampling 
techniques. Furthermore, this PDMS chip enabled reversible sealing, allowing its re-use, 
and the integration of multilayer valves to automate selection of the perfusion buffer 
flowing over the cells.  
This chip design was optimized using computer modelling to reduce temporal 
resolution and ensure sufficient mixing of assay reagents. On-chip enzyme assay 
reactions were also optimized by altering reagent flow rates and modifying the PDMS 
surface to prevent analyte (NEFA) adsorption/loss. The multiplexed assay chip had linear 
calibration curves when perfused with standards, and had limits of detection of 6 µM for 
the NEFA assay and 5 µM for the glycerol assay. Adipocytes were perfused with basal 
buffer followed by an isoproterenol solution (to stimulate lipolysis). This stimulation 
resulted in a 1.5- to 6-fold increase in NEFA and glycerol concentration over basal levels. 
In addition, it was also observed that NEFA:glycerol ratios varied as the cells aged, 
implying different capacity for NEFA recycling with cellular maturation. 
Using this dual assay chip, comparisons in NEFA re-esterification were also 
drawn between on-chip perfusion/detection and static incubation/off-line analysis. It was 
found that the fold increase of ~1.6 with isoproterenol application over basal levels was 
consistent between both techniques. However, cell adipocyte perfusion resulted in less 
NEFA recycling for both the basal and isoproterenol conditions than static incubation. It 
would follow that since the NEFAs are secreted into a flowing solution, they are less 
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available to be re-esterified, which could imply something about the kinetics of cellular 
uptake. Stimulation dynamics were also investigated by supplying short pulses of 
isoproterenol to the cells. It was found that application of 60 s or less resulted in a brief 
elevation in lipolysis that then reverted to basal levels in ~50 min. These findings could 
also imply kinetics of adipocyte stimulation pathways, which is useful to further 
mechanistic understanding of adipocytes. 
The second chip developed and described in Chapter 3 allowed on-line MS 
analysis of microfluidic adipocyte perfusate. While the multiplexed assay chip allowed 
detection of NEFAs, it could only quantify total NEFA concentration. A variety of 
different NEFAs are secreted from adipocytes, so it was of interest to have a detection 
method that could identify the NEFAs released into circulation. Cells were perfused in a 
similar manner to the other chip design, but instead of an enzyme assay reaction channel, 
an injection loop was constructed downstream of the cell chamber. Prior to MS detection, 
a SPE bed was used to remove buffered media salts to improve ESI efficiency.  However, 
this SPE bed created back pressure that was unfavorable to the cells. To fluidically isolate 
the cells from the packed bed, multilayer, pneumatically-actuated valves were integrated 
into the PDMS chip. With this chip, 8 NEFAs were successfully identified with MS 
detection under basal and lipolysis-stimulated conditions. All but one of the detected 
NEFAs had statistically significant increases in release with the application of 
isoproterenol/forskolin, ranging from 1.2- to 1.9 fold elevation over basal concentrations.  
While these chips were designed for adipocyte secretion studies of lipolysis 
products, the general layout is versatile and could be applied to a variety of secreted 
metabolites or cell types, leading to greater understanding of cellular systems.  
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Future Directions 
 In regards to the chips developed in this dissertation, there are many directions 
that could be pursued for their further improvement and application. These potential 
biological uses and analytical enhancements are detailed in the following section. 
Alternate Detection Schemes for Dual Enzyme Assay Chip 
 The PDMS chip described in Chapter 2 was developed to monitor 2 metabolites 
secreted from adipocytes in parallel. This was accomplished through the integration of 
reaction channels that enabled on-line use of a fluorescently-modified commercially 
available enzyme assay. Transparent chips (i.e. PDMS) can be placed on a microscope 
stage or homemade optics set-up, and excitation and emission light can be easily 
transmitted. The inverted microscope used for LIF detection of the dual assay chip was 
equipped with a CCD camera for fluorescence emission collection and data recording, 
allowing both outlet channels to be imaged simultaneously. While this technique was 
straightforward and robust, it somewhat negates the miniaturized footprint of the 
microfluidic device. Furthermore, if this general chip design were used with other cell 
lines on chip, fluorescent enzyme assays for the analytes of interest may not be available 
and could require another detection mode. 
Electrochemical Detection 
 Both the NEFA and glycerol enzyme assay reaction schemes create one 
equivalent of hydrogen peroxide. This product is electroactive and could be readily 
detected with electrochemical detection on chip.5.2 Many groups have demonstrated 
deposition of various types of electrodes for detection of a range of analytes.5.3-7 
Electrodes could be placed in the 2 assay outlet channels of the PDMS chip. Additionally, 
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with electrochemical detection, the fluorogenic dye, Amplex UltraRed, wouldn’t be 
necessary, reducing reagent cost for the system. 
Fiber Optics 
 Our group has developed a fiber optic detection platform for fluorescent product 
sensing (currently in preparation for publication). These probes are 1.1 mm x 0.5 mm, 
and include a series of air gaps enclosed in PDMS to act as light filters and mirrors, 
illustrated in Figure 5.1a. The probes are portable, and can simply be placed on 
microfluidic channels for detection, like that used for the on-chip glycerol enzyme assay. 
As shown in Figure 5.1b, step changes between different glycerol standards were readily 
detected, with a R2 of 0.988 and LOD of 0.7 µM. Two of these probes could be 
positioned over the outlet channels on the dual assay chip, with the potential of expansion 
beyond just 2 channels if more parallel assays were integrated onto a similar chip design. 
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Figure 5.1: Microfabricated fluorescence fiber optic probe (a) and calibration step 
plots of on-chip glycerol enzyme assay, measured with the probe (b). 
Low-cost Absorbance Detector 
 Another product developed in our lab, an absorbance detector, could be 
implemented with the dual assay chip. This detector was created with 3D printing; a 2 cm 
x 2 cm black polymer cube was constructed with a channel through the center and an 
enclosure for a light source. Transparent tubing (i.e. fused silica capillary with a burned 
window) is fed through the center channel, wherein the dye of interest can be flowed. 
Various wavelength LED lights can be integrated into the detector depending on the 
necessary excitation source needed for the dye. The read-out of the system is operated 
with Arduino electronics and can be connected to a computer via USB-port. Capillary 
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from the outlet channels of the dual assay could be connected to 2 of these detectors. As 
with electrochemical detection, the fluorogenic dye would not need to be added to the on-
chip assays, as the commercially available enzyme assays are designed to be used with 
colorimetric detection. Besides the significant size reduction compared to a fluorescent 
microscope, this detector can be multiplexed and transported.  
Injection Loop Chip Improvements 
 To create a more automated, on-line injection loop for MS detection of cell 
secretion, a few of the current off-chip components could be integrated onto the chip 
described in Chapter 3. While the initial study used an off-chip SPE bed coupled to the 
device, this bed could also be packed on chip, downstream of the injection loop. This can 
be accomplished by creating a ‘moat’ at the outlet; the channel height could be decreased 
to 12 µm for ~100 µm using the same fabrication procedure as that used for the valve 
regions. The 20 µm particle slurry could be pumped into the chip through the outlet and 
packed against the moat. To prevent the particles from flowing back through the outlet 
during normal operation, a short length of 40/150 could act as a frit. This capillary could 
be directly connected to a metal-coated capillary spray tip for ESI-MS. This on-chip 
packing method was constructed (as shown in Figure 5.2), but has not yet been tested. 
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Figure 5.2: Moat design for on-chip SPE packing. (a) Schematic of channel 
dimensions and (b) 20 µm particles packed in a PDMS channel.  
 Another on-chip addition that could be implemented is a set of valves at the 
wash/elution solvent inlet as highlighted in red in Figure 5.3. This would eliminate the 
need for an off-chip 4-port valve to switch between solutions introduced on chip, further 
integrating solvent delivery. Finally, the volume of the injection loop could be decreased, 
improving the throughput of the method by shortening the time required for each 
injection. The current 7.5 µL design was implemented to ensure enough analyte was 
loaded onto the SPE bed for injection, but could be decreased to ~5 µL and still be able to 
detect NEFA levels above the LOD of the assay. 
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Figure 5.3: Proposed injection loop chip design with added valve at the wash/elution 
solvent inlet. 
Droplet Reagent Addition 
 While the dual assay chip developed in Chapter 2 improves automation and 
temporal resolution of cell secretion sampling compared to traditional off-line methods, 
the assays still have a temporal response of 2 minutes. To understand more rapid changes 
that are occurring in regards to cell secretion, it would be advantageous to reduce the 
temporal response of the system. The flow through the chamber has been optimized to 
reduce temporal resolution with computer modeling, but the enzyme assay reaction 
channels are relatively long (to allow adequate mixing and assay incubation times) and 
are subject to the effects of Taylor dispersion. Segmenting flow after the cell chamber 
could circumvent this problem. Droplets are created by the addition of immiscible oil 
phase to an aqueous stream, forming discrete sample plugs. Droplets allow rapid, 
efficient mixing of reagents and also maintain temporal information within the discrete 
plugs.5.8  
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 For implementation with the dual assay chip, an oil inlet channel would have to 
be constructed downstream of the cell chamber, before the flow split. Alternately, 2 oil 
inlets could be integrated after the flow split. Once the droplets have been formed, 
additional inlets for the enzyme assay reagents could add the appropriate amounts of the 
enzyme to the droplets, controlled by relative flow rates of the fluid streams. 
Optimization of the assay reactions would have to be performed to get maximum readout 
signal, but with the more efficient mixing and smaller reaction ‘vessels’, it’s possible that 
the incubation times would be lower. This would allow shorter channels, and the use of 
droplets would remove the necessity of having 2 different channel widths in the enzyme 
reaction portion of the chip. Detection of the reaction products could be accomplished 
with LIF or the 3D-printed absorbance detector.  
A few potential challenges are envisioned with the formation of droplets on chip, 
but different options are available to remedy these problems if they occur. The first is that 
the addition of an oil stream to an aqueous stream can cause some back pressure, which if 
great enough, would not be suitable for coupling to a chip containing cells (for reasons 
mentioned in previous chapters). Flow rates may have to be optimized if this effect is 
great enough to damage the cells. The other potential challenge would be the affinity of 
NEFAs to the oil phase, resulting in a loss of detectable analyte. This may not be a 
problem if the NEFAs are bound to BSA or react readily with the assay reagents; 
however various surfactants could also be added to the oil phase to potentially prevent the 
loss of NEFAs. 
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Monitor Lipolysis from eMSCs and Primary Adipocytes 
 Experiments with the 2 chip designs presented in this dissertation were conducted 
with 3T3-L1 adipocytes. For initial experiments, these are the ideal cell types to work 
with because they are relatively easy to obtain and culture, and adhere well to surfaces 
without any modifications. As previously discussed, 3T3-L1 are not the best genetic 
models for understanding in vivo adipocyte physiology, containing multilocular lipid 
droplets and missing chromosomes. Ear mesenchymal stem cells (eMSCs) would be of 
interest to load into the cell chamber of the dual assay chip. These cells are taken directly 
from a tissue punch of a mouse ear, making them a primary cell model and more 
physiologically relevant. According to studies, eMSCs differentiate more robustly into 
adipocytes than preadipocytes isolated from stromal-vascular tissue.5.9, 10 These cells can 
also be grown on coverslips as the 3T3-L1 adipocytes were; if loaded into the PDMS cell 
chamber, lipolysis and NEFA recycling could be investigated under perfusion conditions 
(with dual assay or MS detection), not previously investigated. Additionally, if the mice 
were bred with a genetic knockout, the eMSCs will also contain that same genetic 
makeup which will enable the study of how various genes regulate lipolysis mechanisms. 
While primary adipocytes (mature adipocytes collected from dissected fat pads) 
are more difficult to handle, they would be the most ideal adipocyte to study. Primary 
adipocytes are unilocular, have been differentiated with endogenous regulation, and were 
exposed to the circulating signaling molecules and conditions of the in vivo environment. 
Primary adipocytes have been loaded in perfusion columns for analysis of lipolysis 
regulation, but required large cell and reagent volumes as well as off-line fraction 
collection and analysis. More automated analysis of primary adipocytes could be 
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accomplished using microfluidic devices. Additionally, one advantage of using primary 
adipocytes is that they can be collected from different fat depots for analysis; it has been 
shown that fat depots (subcutaneous, visceral, marrow, etc.) exhibit various morphologies 
and functions5.11-13, and further understanding of regulation in the different depots could 
provide a better picture of systemic white adipose tissue physiology. 
A new cell chamber construction would have to be developed to load primary 
adipocytes onto a microfluidic chip. After digestion of the tissue, isolated primary 
adipocytes float in a suspension of media. An inverted cell chamber (from that developed 
in previous chapters) could be fabricated, with the bulk of the chamber area above the 
fluid path instead of below. Another option would be to load an aliquot of cells into the 
chamber of the existing dual assay chip, cover with a thin, permeable membrane and seal 
the chip. This would keep the cells sequestered in the lower portion of the chamber, while 
still being able to sample secreted metabolites. This was briefly tested on-chip; the chip 
was able to be reversibly sealed without leaking from the added membrane, but further 
optimization of the flow parameters need to be conducted to acquire adequate signal due 
to the slower diffusion rates of metabolites through the membrane (compared to direct 
fluid flow). A third method would be to modify the surface of the coverslips with a cell 
adhesion agent like poly-l-lysine or Cell-Tak; the coverslips could then be loaded into the 
previously developed cell chamber, but control studies would have to be performed to 
ensure the adhesion agent doesn’t interfere with the inherent function of the cell. Once 
implemented on chip, studies investigating the lipolysis and NEFA recycling rates of 
primary cells from different depots could be performed by enzyme assay or MS 
detection, and compared to cultured lines and previous reports. 
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Widening scope of on-chip adipocyte stimuli 
 In all of the experiments conducted in this dissertation with adipocytes on-chip, 
the cells were perfused with basal buffer and a positive control to increase lipolysis 
(isoproterenol or forskolin). While great proof-of-concept studies, it would be interesting 
to see the lipolytic response of adipocytes under a variety of stimuli. Adipocytes are 
responsive to subtle changes in their surroundings (chemical or mechanical); these could 
be elucidated with microfluidic assays and online detection. A myriad of chemical stimuli 
and pharmaceutical drugs have been tested on adipocytes in static culture, but as 
observed in Chapter 4, there are differences in the secretion of lipolysis products with 
continuous cell perfusion. For example, physiological concentrations of insulin act to 
inhibit lipolysis, whereas glucagon, TNFα and glucocorticoids increase lipolysis as 
illustrated in Figure 5.4.5.14 These chemical stimuli could be perfused over the cells 
acutely or for long periods of time to monitor temporal changes with cell secretion. As 
demonstrated in Chapter 4, if cells are stimulated for 60 s or less with isoproterenol 
before adding these other stimuli, the isoproterenol will act as a positive control for 
lipolysis within the same experiment/group of cells. Furthermore, these chemical stimuli 
could be used with knock-out eMSC models or primary adipocytes from different depots, 
proposed in the previous section, to gain more knowledge about cellular conditions that 
effect lipolysis, and thereby our understanding of this dynamic tissue. 
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Figure 5.4: Schematic of adipocyte with different chemical stimuli regulatory action 
on fatty acid (FA) storage/lipolysis. Insulin promotes FA re-esterification into the 
lipid droplet, and inhibits lipolysis. Adenosine and a-catecholamines also inhibit 
lipolysis, whereas b-catecholamines, growth hormones promote lipolysis. Adapted 
by permission from Macmillan Publishers Ltd: International Journal of Obesity, 
copyright 2003.5.14 
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APPENDIX A  
 
FABRICATION AND OPERATION TIPS 
 
PDMS Microfluidic Chip Fabrication 
60 µm SU-8 channels: 
1. If necessary, clean Si wafer with IPA. 
2. Spin coat on ~1 mL HDMS (1000 rpm for 15 s) 
3. Spin coat SU-8 2075 photoresist (pre-spin 500 rpm for 10 s, 4000 rpm for 60 s) 
4. Pre Bake: 3 min at 65 °C, 8 min at 95 °C 
5. Align photomask (dark-field) on wafer and expose to UV for 13.3 s 
6. Post Bake: 2 min at 65 °C, 6 min at 95 °C 
7. Develop in SU-8 developer (~5 min, until rinsed clean with IPA) 
12 µm AZ 9260 channels: 
1. Spin coat AZ 9260 photoresist (pre-spin 500 rpm for 10 s, 4000 rpm for 60 s) 
2. Heat for 2 min at 95 °C 
3. Align mask (clear-field) on wafer and expose to UV for 60 s 
4. Develop in 20 mL AZ 400K developer and 50 mL water (rinse with water) 
5. Heat at ~125 °C for 5 min to round features 
PDMS: 
1. Mix 10:1 (base:curing agent) PDMS prepolymer 
2. Degas until all bubbles are removed (let sit or in vacuum chamber) 
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3. Pour over wafer master for thick layer (in Petri dish or make containment area 
with aluminum foil) or spin for thin layer (~170 µm, pre-spin 500 rpm for 8 s, 
1500 rpm for 40 s) 
4. Bake at 80 °C until firm (20-30 min for thick layer, 5-10 min for thin layer) 
5. Cut out PDMS and peel away from wafer (thick layer) (Tip: if using Petri dish 
containment, cut just inside wafer edge with razor blade; if you run off the edge of 
the wafer with the blade it will likely shatter) 
6. Use corona discharge and oxidize the surface 
7. Bond to another oxidized surface and press to remove all bubbles between layers 
8. Bake at 80 °C for 5-10 min to irreversibly bond layers 
Dual Assay Chip Set-Up 
Calibration: 
1. Perfuse outlet channels with 20 mM SDS at 1.5 µL/min for ~ 1 hr, followed by 
water for ~10 min 
2. Degas chip in vacuum chamber for at least 1 hr 
3. While degassing:  
a. Rinse syringes, remove all bubbles 
b. Flush unions and capillary connections with water 
c. Set up syringe pumps and valve system by microscope 
d. Prepare standards/reagents as necessary 
e. Fill syringes with solutions and put on pumps 
f. Start flow and make sure no bubbles in Teflon connections 
g. Pause flow until chip on microscope 
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4. Take chip out of vacuum chamber and perfuse outlet with water, flush all 
capillaries with water 
5. If valve channels are empty, fill with water and connect to nitrogen to force water 
into control channels (will leach air into solutions during first experiment 
otherwise) 
6. Put glass coverslip in lower cell chamber, put few drops of water (or red food dye; 
good for flow visualization and slightly fluorescent so can position channels, but 
allow longer rinse time after solution connection before starting expt to get true 
blank signal) on coverslip 
7. Align top chip over lower chip using the dimensions of cell chamber and 
seal/squeeze out liquid and air between layers with back of tweezers 
8. Thread control tubing through top compression frame and assemble compression 
frame 
9. Once on microscope (**make all connections slowly) 
h. Start with perfusion of blank through valve 
i. Turn on valves and switch a few times 
j. Switch to blank going to valve waste and connect extra length of capillary 
(filled with water) 
k. Switch few more times, then when on waste flow direction, put end of 
capillary in vial of water & leave for remainder of expt (BSA will quickly 
clog capillaries without flow) 
l. Switch so blank flow is through chamber and connect low concentration 
standard capillary 
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m. Connect extra length of capillary (filled with water) to other valve waste & 
put in vial of water 
n. Connect glycerol reagent, CR-A, AUR on glycerol side, CR-B, AUR on 
NEFA side, in that order 
o. Check with microscope to make sure flow is going in correct direction at 
all inlets 
p. Let flow for ~ 10 min before recording starts 
 
Figure A.1: Set-up and operation diagram for dual assay chip. 
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APPENDIX B  
 
OFF-LINE ASSAY PROTOCOLS 
 
Fatty Acid Fluorescence Assay Protocol: 
• 10 µL standard or sample 
• 50 µL Wako Color Reagent A (1.66x concentrated from Wako directions) 
• Vortex, RT incubation (duration of starting glycerol assay) 
• 6 µL 10 mM Amplex UltraRed (made by adding 340 µL DMSO to 1 mg vial) 
• 25 µL Wako Color Reagent B 
• Vortex, RT incubation 
• Triplicate sampling with 20 µL per well in low volume  384-well plate 
• Plate reader settings: 
o Excitation wavelength: 535 nm 
o Emission wavelength: 620 nm 
o PMT voltage: 620 V 
o Light intensity: 10 
Glycerol Fluorescence Assay Protocol: 
• 10 µL standard or sample 
• 4.5 µL 10 mM Amplex UltraRed 
• 90 µL Sigma Free Glycerol Reagent 
• Vortex, RT incubation 
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• Triplicate sampling with 20 µL per well in low volume  384-well plate 
• Plate reader settings: 
o Excitation wavelength: 535 nm 
o Emission wavelength: 620 nm 
o PMT voltage: 620 V 
o Light intensity: 10 
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APPENDIX C  
 
COMSOL MODELING OF MICRODIALYSIS PROBE 
 
The following document is the 3D COMSOL set-up for monitoring diffusion of 
neurotransmitters through a microdialysis probe. As a supplement to a project 
investigating the neuronal turnover of glutamine (GLN) to glutamate (GLU), a COMSOL 
model of a microdialysis probe to look at recovery of GLN and GLU was developed. 
Based on parameters obtained with in vitro and in vivo experiments, the dialysis 
membrane diffusion coefficient, and appropriate rate constants for the conversion of GLN 
to GLU were determined. These values could be used with other models to predict 
recovery with other conditions. The final model was run on COMSOL version 4.4.  
 c_all represents GLN 
 r_all represents ‘intracellular’ GLN 
 y_all represents GLU 
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Figure C.1: Experimental reaction scheme modeled with COMSOL. Diffusion of 
GLN and GLU through microdialysis probe was simulated along with theoretical 
neuronal turnover of GLN to GLU. 
 
 
 
• Global Definitions 
o Parameters 
Name Expression 
V 1.667e-11 [m^3/s] 
M 0.0002 [m/s] 
Dp 8.6e-10 [m^2/s] 
Dv 3.2e-10 [m^2/s] 
Dm 5.3e-11 [m^2/s] 
k1 10 [1/s] 
k2 100 [1/s] 
k3 100 [1/s] 
sc 8 
c0 0.0025 [mol/m^3] 
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• Model 1 
o Definitions 
 Explicit> select domains, rename dialysate 
 Explicit> select domain, rename membrane 
 Explicit> select domain, rename brain 
 Variables 1> selection: dialysate, name: c_all, expression: c1 
selection: dialysate, name: r_all, expression: r1 
selection: dialysate, name: y_all, expression: y1 
 Variables 2> selection: membrane, name: c_all, expression: c2 
selection: membrane, name: r_all, expression: r2 
selection: membrane, name: y_all, expression: y2 
 Variables 3> selection: brain, name: c_all, expression: c3 
selection: brain, name: r_all, expression: r3 
selection: brain, name: y_all, expression: y3 
 Step1> location: 3 (time to make step), from: 0, to: 1 
 Step2> location: 5 (time to make step), from: 0, to: 1 
 Average 1> name: outlet, manually select outlet 
o Geometry (set to mm) 
 Inner Membrane 
• Radius (R): 0.1 
• Height (H): 2.1/sc 
• {0, 0, 0} 
 Outer Membrane 
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• R: 0.108 
• H: 2.1/sc 
• {0, 0, 0} 
 Outer long capillary 
• R: 0.049 
• H: 2/sc 
• {-0.05, 0, 0} 
 Inner long capillary 
• R: 0.02 
• H: 2/sc 
• {-0.05, 0, 0} 
 Workplane 1 
• R: 0.02 
• {0.05, 0} 
 Bottom Plug 
• R: 0.108 
• H: 0.02/sc 
• {0, 0, 2.1/sc} 
 Vial/Brain Region 
• R: 0.308 
• H: 2.4/sc 
• {0, 0, 0} 
 Sphere 1 
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• R: 0.005 
• {0.115, 0, 0.02} 
 Array 1 
• Size: {4, 1, 75/sc} 
• Displacement: {0.05, 0, 0.03} 
 Rotate 1 
• Keep input objects: ON 
• Rotation: {0, 45, 90, 135, 180, 225, 270, 315} 
• Axis of rotation: {0, 0, 0} 
 Sphere 2 
• R: 0.005 
• {-0.115, 0, 0.02} 
 Array 2 
• Size: {4, 1, 75/sc} 
• Displacement: {-0.05, 0, 0.03} 
 Rotate 2 
• Keep input objects: ON 
• Rotation: {22.5, 67.5, 112.5, 157.5, 202.5, 247.5, 292.5, 
337.5} 
• Axis of rotation: {0, 0, 0} 
o Materials 
 Don’t enter anything here 
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o Laminar Flow 1> select dialysate domain (within membrane and inner 
long capillary) 
 change to incompressible flow 
 Fluid Properties 1> density: 993 kg/m3, viscosity: 0.000692 Pa·s 
 Wall 1> default settings 
 Initial values 1> default settings 
 Inlet> select boundary, laminar inflow flow rate: V/sc,  entrance 
length: 0.00001, check ‘constrain endpoints to zero’ 
 Outlet 1> select boundary 
o Transport of Diluted Species 1> select dialysate domain, keep 
‘convection’ box checked 
 Convection and Diffusion 1> Velocity Field: Velocity Field, 
Diffusion Coefficient> select diagonal, and for Dzz, enter Dp/(sc2) 
i.e.  
Dp 0 0 
0 Dp 0 
0 0 Dp/sc2 
 
 No Flux 1: Default settings 
 Initial values 1> concentration c1: 0 
 Flux 1> check ‘species c1’, enter M*(c2- c1) 
check ‘species r1’, enter M*(r1- r2) 
check ‘species y1’, enter M*(y2- y1) 
 Inflow 1> select boundary, enter: c0 
 Outflow 1> select boundary 
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o Transport of Diluted Species 2> select membrane domain, uncheck 
‘convection’ box 
 Diffusion> select diagonal, and for Dzz, enter Dm/(sc2) 
 No Flux 1: Default settings 
 Initial values 1> concentration c2: 0 
 Flux 1> check ‘species c2’, enter M*(c1-c2) 
check ‘species r2’, enter M*(r2-r1) 
check ‘species y2’, enter M*(y1-y2) 
 Flux 2> check ‘species c2’, enter M*(c3-c2) 
check ‘species r2’, enter M*(r2-r3) 
check ‘species y2’, enter M*(y3-y2) 
o Transport of Diluted Species 3> select brain domain, uncheck 
‘convection’ box 
 Diffusion> select diagonal, and for Dzz, enter Db/(sc2) 
 No Flux 1: Default settings 
 Initial values 1> concentration c3: 0 
 Flux 1> check ‘species c3’, enter M*(c2- c3) 
check ‘species r3’, enter M*(r3- r2) 
check ‘species y3’, enter M*(y2- y3) 
 Reactions 1> select brain region 
c3: k1*y3*step1(t[1/s]) 
r3: 0 
y3: -k1*y3*step1(t[1/s]) 
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 Reactions 2> select sphere array 1 
c3: -k2*c3*step2(t[1/s]) 
r3: k2*c3*step2(t[1/s]) 
y3: 0 
 Reactions 3> select sphere array 2 
c3: 0 
r3: k3*r3*step3(t[1/s]) 
y3: 0 
o Mesh (started w/ physics controlled mesh then changed to the following 
settings) 
 Size 
• Calibrate for: Fluid Dynamics 
• Fine 
 Size 1 
• Calibrate for: Fluid Dynamics 
• Domains: dialysate 
• Coarse 
 Size 2 
• Calibrate for: Fluid Dynamics 
• Boundaries: dialysate 
• Fine 
 Size 3 
• Calibrate for: Fluid Dynamics 
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• Boundaries: brain 
• Normal 
 Corner Refinement 
• Domain dialysate 
• Boundaries: dialysate 
• Minimum angle between boundaries: 240 deg 
• Element Size Scaling Factor: 0.35 
 Free Tetrahedral 1 
• Domain: dialysate 
 Boundary layers 
• Boundary layer properties (pre-set variables): dialysate 
domain 
o Boundary layers: 2 
o Boundary layer stretching factor: 1.2 
o Thickness adjustment factor: 5 
 Free Tetrahedral 2 
• Remaining 
• Study 1 
o Step 1: Stationary> check only ‘laminar flow’ modules 
 Enable ‘Direct’ solver 
• Study 2 
o Step 1: Time Dependent> check everything except ‘laminar flow’, set time 
range, under ‘Values of Dependent Variables’ check ‘values of variables 
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not solved for’ and choose method: ‘solution’, study: ‘study 1, stationary’, 
selection: ‘automatic’ 
 Enable ‘Direct’ solver 
 Changed to ‘Fully Coupled’ solved instead of segregated 
 Time-Dependent Solver 1> Time stepping> Change initial step to 
0.5 s and max step to 1 s 
• Results 
o Under ‘Data Sets’ add 3D Cut Line 
(mm) X Y Z 
Point 1 0 0 0.11 
Point 2 1 0 0.11 
 
o Concentration 
 Slice 1: change c1 to c_all or r_all 
o 1D Plot Group 
 Global 
• Select appropriate solver in data set 
• Enter outlet(c_all) 
o 1D Plot Group 
 Global 
• Select appropriate solver in data set 
• Enter outlet(r_all) 
o 1D Plot Group 
 Global 
• Select appropriate solver in data set 
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• Enter outlet(y_all) 
o 1D Plot Group 
 Line Graph 
• Select Data Set: 3D Cut line 
• Enter c_all in y-axis data ‘expression’ 
• Change x axis data parameter to ‘expression’ and enter x 
o 1D Plot Group 
 Line Graph 
• Select Data Set: 3D Cut line 
• Enter r_all in y-axis data ‘expression’ 
• Change x axis data parameter to ‘expression’ and enter x 
o 1D Plot Group 
 Line Graph 
• Select Data Set: 3D Cut line 
• Enter y_all in y-axis data ‘expression’ 
• Change x axis data parameter to ‘expression’ and enter x 
 Experiment 1 - Well stirred matching: 
• Additional laminar flow modules are activated in study 1 in brain region 
• Transport of Diluted Species 3 has convection box checked, and is linked to 
Velocity Field (spf2.U) in Convection and Diffusion tab 
• Reaction 1 & Reaction 2 in Transport of Dilute Species 3 are deactivated 
• Vary membrane diffusion coefficient 
 Experiment 2 – In Vivo Matching ([Gln]): 
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• Only Laminar Flow module 1 is activated in study 1 
• Transport of Diluted Species 3 is only Diffusion dependent 
• Only Reaction 1 in Transport of Dilute Species 3 is activated 
• Vary k1 & k2 
 Experiment 3 – In Vivo Matching ([Glu]): 
• Only Laminar Flow module 1 is activated in study 1 
• Transport of Diluted Species 3 is only Diffusion dependent 
• Only Reaction 1 in Transport of Dilute Species 3 is activated 
• Vary k1 & k2 
 Experiment 4 – In Vivo Matching ([Glu], by adding decay rxn): 
• Only Laminar Flow module 1 is activated in study 1 
• Transport of Diluted Species 3 is only Diffusion dependent 
• Reaction 1 & Reaction 2 in Transport of Dilute Species 3 are activated 
• Vary k3 
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Figure C.2: Modeling of microdialysis probe in vivo. (A) Diagram of COMSOL 
model with reaction domain highlighted in the legend. (B) Flux of infused GLN 
across dialysis membrane and concentration profile across regions, with varied 
brain ‘consumption’ reaction rates. (C) Measurement of concentration profiles for 
infused GLN, and GLU formed outside the probe (k1 = 10, k2 = 100, k3 = 100 s-1). 
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APPENDIX D  
 
COMSOL MODELING OF DUAL ASSAY CHIP 
 
The following document is the 2D COMSOL set-up for the dual enzyme assay chip 
used in Chapters 2 & 4. This model was used to determine experimental flow rates and 
ensure sufficient mixing of reagents. The final model was run on COMSOL version 4.3b.  
• Global Definitions 
o Parameters 
Name Expression 
inlet 1.25e-11 [m^3/s] 
gly 9.67e-12 [m^3/s] 
FA 5.0e-12 [m^3/s] 
 
• Model 1 
o Definitions 
 Step1> location: 0.2 (time to make step), from: 0, to: 1 
 Average 1> name: outlet1, manually select outlet 1  
 Average 2> name: outlet2, manually select outlet 2 
 Average 3> name: pointA, manually select point A (after built) 
 Average 4> name: pointB, manually select point B 
o Geometry (set to mm) 
 Imported from AutoCAD 
 Added point in the middle of channel after flow split, before first 
inlet 
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 Mirror point to other side of flow split 
 
o Materials 
 Water, liquid 
o Laminar Flow 1> select entire domain 
 change to incompressible flow 
 check ‘Use shallow channel approximation’ 
 Channel thickness: 0.00006 
 Fluid Properties 1> default settings 
 Wall 1> default settings 
 Initial values 1> default settings 
 Inlet 1> select appropriate boundary, laminar inflow flow rate: 
inlet, entrance length: 0.00001, check ‘constrain endpoints to zero’ 
(use for all inlets) 
 Inlet 2> select appropriate boundary, laminar inflow flow rate: gly 
 Inlet 3> select appropriate boundary, laminar inflow flow rate: FA 
 Inlet 4> select appropriate boundary, laminar inflow flow rate: FA 
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 Inlet 5> select appropriate boundary, laminar inflow flow rate: FA 
 Outlet 1> select boundaries 
o Transport of Diluted Species 1> select entire domain, keep ‘convection’ 
box checked 
 Convection and Diffusion 1> Velocity Field: Velocity Field (spf) 
 No Flux 1: Default settings 
 Initial values 1> concentration c1: 0 
 Inflow 1> select top inlet boundary, enter: 0.5*step1(t[1/s]) 
 Inflow 2> select remaining inlet boundaries, enter: 0 
 Outflow 1> select 2 outlet boundaries boundary 
o Mesh (physics controlled mesh) 
 Calibrate for: Fluid Dynamics, Fine 
• Study 1 
o Step 1: Stationary> check only ‘laminar flow’ module 
 Enable ‘Direct’ solver 
• Study 2 
o Step 1: Time Dependent> check only ‘transport of diluted species’, set 
time range, under ‘Values of Dependent Variables’ check ‘values of 
variables not solved for’ and choose method: ‘solution’, study: ‘study 1, 
stationary’, selection: ‘automatic’ 
 Enable ‘Direct’ solver 
 Changed to ‘Fully Coupled’ solved instead of segregated 
 Time-Dependent Solver 1> Default settings 
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• Results 
o Under ‘Data Sets’ add 2D Cut Line 
o View velocity (Figure D.1) and concentration plots 
o 1D Plot Group 
 Global 
• Select appropriate solver in data set 
o 1D Plot Group 
 Line Graph 
• Select Data Set: 2D Cut line 
• Change x axis data parameter to ‘expression’ and enter x 
 
Figure D.1: Velocity plot of flow through dual assay chip. 
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Measuring Flow Split Ratio with Varying Downstream Inlet Flow Rates 
• Use 1D plot group, enter ‘pointA’ and ‘pointB’ as expressions, compare 
velocities (spf.U), results shown in Figure D.2 
 
Figure D.2: Flow split analysis of dual assay chip. (A) Diagram of chip and 
measurement points. (B) Flow velocity at points A & B were monitored while 
glycerol reagent flow rates were varied. 
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Measuring Delay Time and Temporal Response 
• Use 1D global plot group, enter ‘outlet1’ as expression, measure concentration 
(c1), repeat with ‘outlet2’, shown in Figure D.3 
• Rise time measured as 10-90% of the step change and delay time measured as 
the time of concentration change to 10% if the step change 
o NEFA Side: 11.5 min delay time, 1.3 min rise time 
o Glycerol Side: 9.2 min delay time, 1.2 min rise time 
 
Figure D.3: Step change plot of dual assay chip. Top inlet flow rate changed from 0 
to 0.5 mM (other inlets remained at 0 mM, hence the varying maximum 
concentrations). 
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Measuring Reagent Mixing After Inlets 
• Use 1D line group, select 2D cut line (a few cut lines positioned across 
channels after inlets), measure concentration (c1), shown in Figure D.4 
 
Figure D.4: On-chip reagent mixing efficiency. (A) Pictoral representation of 2 
concentrations of a chemical species mixing at a reagent inlet on the dual assay chip. 
(B) Concentration of the chemical species was measured across the width of the 
channel at various distances from the reagent inlet. 
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APPENDIX E  
 
COMSOL MODELING OF MICROFABRICATED PROBE 
 
Modeling Set-up Procedures 
The following document is the 3D COMSOL set-up for monitoring diffusion of 
dopamine through a microfabricated porous membrane, to support a collaborative 
research project. The porous membrane was etched into the side of a novel fabricated 
microdialysis probe, which reduces the spatial resolution of in vivo neurochemical 
monitoring. The model helped identify the theoretical porosity and recovery of the probe. 
The final model was run on COMSOL version 4.4.  
 
 
• Global Definitions 
o Parameters 
Name Expression 
diff 6e-10 [m^2/s] 
por 0.3 
  
• Model 1 
o Definitions 
 Variables 1> selection: domain 1, name: c_all, expression: c 
 Variables 2> selection: domains 2 & 3, name: c_all, expression: c2 
 Average 1> name: outlet, manually select outlet 
o Geometry (set to mm) 
 Block1 
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• 0.06, 0.023, 4 (W, D, H) 
• {0, 0, 0} 
  Block2 
• 0.06, 0.023, 4 (W, D, H) 
• {0.075, 0, 0} 
 Block3 
• 0.135, 0.023, 0.06 (W, D, H) 
• {0, 0, 3.94} 
 Union1 
• Blocks 1-3 
 Block4 
• 0.06, 0.005, 4 (W, D, H) 
• {0, 0.023, 0} 
 Block5 
• 0.06, 0.005, 4 (W, D, H) 
• {0.075, 0.023, 0} 
 Block6 
• 0.135, 0.005, 0.06 (W, D, H) 
• {0, 0.023, 3.94} 
 Union2 
• Blocks 4-6 
 Block7 
• 1, 1, 4.5 (W, D, H) 
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• {-0.45, 0.028, 0} 
o Materials 
 Water, liquid (Domains 1-2) 
 Poly-Si (Domain 3, Young’s Modulus = 160e9 Pa, Poisson’s ratio 
= 0.22, Density = 2320 kg/m^3) 
o Free and Porous Media> select domains 2 & 3  
 change to incompressible flow 
 Fluid Properties 1> default settings 
 Wall 1> default settings 
 Initial values 1> default settings 
 Porous Matrix Properties> select domain 3, permeability: 50e-18 
m^2, porosity: por 
 Inlet> select boundary, laminar inflow flow rate: 100e-9 [L/min],  
entrance length: 0.00001, check ‘constrain endpoints to zero’ 
 Outlet 1> select boundary 
o Species Transport in Porous Media> select domains 2 & 3 
 Mobile Fluid, Immobile Solid> select velocity field, bulk density: 
2320, porosity: por, fluid diffusion coefficient: diff 
 No Flux 1: Default settings 
 Initial values 1> concentration c1: 0 
 Free Flow> select velocity field, diffusion coefficient: diff 
 Inflow 1> select boundary, enter: 0 
 Outflow 1> select boundary 
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o Laminar Flow> select domain 1 
 change to incompressible flow 
 Convection and Diffusion> select velocity field 
 Fluid Properties 1> default settings 
 Wall 1> default settings 
 Initial values 1> default settings 
 Inlet> select boundary 1, laminar inflow flow rate: 0.1 [L/min],  
entrance length: 0.001, check ‘constrain endpoints to zero’ 
 Outlet> select boundary 46 
o Transport of Diluted Species 1> select domain 1, keep ‘convection’ box 
checked 
 Convection and Diffusion 1> Velocity Field: Velocity Field (spf) 
 No Flux 1: Default settings 
 Initial values 1> concentration c1: 0 
 Open Boundary> boundaries 1-2, 5, 46 
 Flux> inward flux: 0.02 [m/s] * (c2-c) 
 Concentration> select boundaries 1-5, 46, concentration: 1  
o Mesh (physics controlled mesh, changed block 7 to coarser) 
• Study 1 
o Step 1: Stationary> check ‘free and porous media flow and laminar flow’ 
modules 
 Enable ‘Direct’ solver 
• Study 2 
 154 
 
o Step 1: Time Dependent> check ‘species transport in porous media and 
transport of diluted species’ modules, set time range, under ‘Values of 
Dependent Variables’ check ‘values of variables not solved for’ and 
choose method: ‘solution’, study: ‘study 1, stationary’, selection: 
‘automatic’ 
 Enable ‘Direct’ solver 
 Changed to ‘Fully Coupled’ solved instead of segregated 
 Time-Dependent Solver 1> Time stepping> Change initial step to 
0.5 s and max step to 1 s 
• Results 
o Under ‘Data Sets’ add 3D Cut Line 1 
(mm) X Y Z 
Point 1 0.03 0 2 
Point 2 0.03 0.3 2 
 
o Under ‘Data Sets’ add 3D Cut Line 2 
(mm) X Y Z 
Point 1 0.105 0 2 
Point 2 0.105 0.3 2 
 
o Concentration 
 Slice 1: change c to c_all 
o 1D Plot Group 
 Global 
• Select appropriate solver in data set 
• Enter outlet(c_all) 
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o 1D Plot Group 
 Line Graph 
• Select Data Set: 3D Cut line 1 
• Enter c_all in y-axis data ‘expression’ 
• Change x axis data parameter to ‘expression’ and enter y 
o 1D Plot Group 
 Line Graph 
• Select Data Set: 3D Cut line 2 
• Enter c_all in y-axis data ‘expression’ 
• Change x axis data parameter to ‘expression’ and enter y 
Results 
 
 The following excerpt based on this model was published in Lee, W. H., et al. 
Anal. Chem. 2016, 88, 1230-1237. 
Comsol modeling and simulation of 1 mM dopamine diffusing through the 
membrane of microfabricated probe. The microfabricated probe was constructed in 
COMSOL Multiphysics 4.4 (Burlington, MA) to model its recovery. The fabricated 
probe has semi-circular fluidic channels; but for ease of modeling, the channels were 
designed as 60 μm x 24 μm rectangles which gave the same cross-sectional area as the 
actual probes. The total length of the channels was 8 mm in a ‘U’ shape like the actual 
probe. The porous membrane was designed as a polysilicon rectangle, 5 μm x 60 μm, 
overlaid the channels. A large box was connected to the external boundary of the 
membrane region for simulating the probe in a well-stirred solution. 
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The ‘Free and Porous Media Flow’ and ‘Species Transport in Porous Media’ 
physics models were applied to the channel and membrane regions. Navier-Stokes 
equations modeled the fluid (water) in the open channel with a flow rate of 100 nL/min. 
Fluid movement in the porous region was defined by the Brinkman equation and a 
permeability of 50 nm2 was used. The porosity variable was modified to match 
experimental data. For the transport of chemical species, the diffusion coefficient of 
dopamine, 6 x10-10 m2/s was used†. The exterior probe volume used ‘Laminar Flow’ and 
‘Transport of Diluted Species’ physics with a flow rate of 10 mL/min to simulate a well-
stirred solution. Images below show cross section of probe at the middle and end of the 
probe color coded for DA concentration.  
 
Figure E.1: A) Recovery for probe with 30% porosity and B) for 0.9% porosity. 
† Gerhardt, G.; Adams, R. N. Anal. Chem. 1982, 54 (14), 2618–2620. 
